TW200811095A - Method for producing 3,3'-dihydroxyisorenieratine and also novel intermediates therefor - Google Patents

Method for producing 3,3'-dihydroxyisorenieratine and also novel intermediates therefor Download PDF

Info

Publication number
TW200811095A
TW200811095A TW096124761A TW96124761A TW200811095A TW 200811095 A TW200811095 A TW 200811095A TW 096124761 A TW096124761 A TW 096124761A TW 96124761 A TW96124761 A TW 96124761A TW 200811095 A TW200811095 A TW 200811095A
Authority
TW
Taiwan
Prior art keywords
formula
isomers
group
doc
mixture
Prior art date
Application number
TW096124761A
Other languages
Chinese (zh)
Inventor
Hansgeorg Ernst
Hagen Jaedicke
Klaus Henrich
Original Assignee
Basf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Basf Ag filed Critical Basf Ag
Publication of TW200811095A publication Critical patent/TW200811095A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/08Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/11Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms
    • C07C37/20Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions increasing the number of carbon atoms using aldehydes or ketones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C37/00Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring
    • C07C37/50Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom of a six-membered aromatic ring by reactions decreasing the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C39/00Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring
    • C07C39/18Compounds having at least one hydroxy or O-metal group bound to a carbon atom of a six-membered aromatic ring monocyclic with unsaturation outside the aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C403/00Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone
    • C07C403/06Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms
    • C07C403/10Derivatives of cyclohexane or of a cyclohexene or of cyclohexadiene, having a side-chain containing an acyclic unsaturated part of at least four carbon atoms, this part being directly attached to the cyclohexane or cyclohexene or cyclohexadiene rings, e.g. vitamin A, beta-carotene, beta-ionone having side-chains substituted by singly-bound oxygen atoms by etherified hydroxy groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5442Aromatic phosphonium compounds (P-C aromatic linkage)
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/28Phosphorus compounds with one or more P—C bonds
    • C07F9/54Quaternary phosphonium compounds
    • C07F9/5456Arylalkanephosphonium compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P23/00Preparation of compounds containing a cyclohexene ring having an unsaturated side chain containing at least ten carbon atoms bound by conjugated double bonds, e.g. carotenes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/09Geometrical isomers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/12Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/16Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated

Abstract

The present invention relates to a novel method for producing 3,3'-dihydroxyisorenieratine of the formula I, and also intermediates of this method.

Description

200811095 九、發明說明: 【發明所屬之技術領域】 本發明係關於一種製備式二羥基異二十二碳烯 樓一偏二甲基本(3,3-<1111}^(11*〇父丫18〇代1116^{61^)(下文稱0,(1)- 胡蘿蔔素-3,3’-二醇)之新穎方法,且亦關於該方法之新穎 中間體。200811095 IX. Description of the invention: [Technical field to which the invention pertains] The present invention relates to a method for preparing a dihydroxyisohexadiene which is a basic dimethyl group (3,3-<1111}^(11*〇父丫A novel method of 18 〇 1116^{61^) (hereinafter referred to as 0,(1)-carotene-3,3'-diol), and also relates to novel intermediates of the method.

【先前技術】 式I之3,3’-二羥基異二十二碳烯撐二偏三甲基苯((1),〇_胡 蘿β素-3,3’-二醇)作為飼料添加劑係極為重要的(br〇iler chicken skin pigmentation: Riv. Zootec. Vet. 1974, 15 31- 44; egg yolk pigmentation: Z. Allg. Mikrobiol. (1970), 10 (4),237-244) ° 在此文獻中闡釋了各種藉由發酵製備φ,φ_胡蘿蔔素_ 3,3’-二醇之方法。該等方法通常具有非常低的空間/時間產 率。另外,為分離出純淨的式;[顏料,需要非常複雜的純 化作業,此使得難以達成工業上經濟的實施方案(j. Ind. Microbiol. Biotechnol. 243 15 64-70 (2000); Riv. Zootec.[Prior Art] 3,3'-dihydroxyisodocosacarbenyltrimethylbenzene of formula I ((1), 〇_胡罗β素-3,3'-diol) as a feed additive Very important (br〇iler chicken skin pigmentation: Riv. Zootec. Vet. 1974, 15 31- 44; egg yolk pigmentation: Z. Allg. Mikrobiol. (1970), 10 (4), 237-244) ° Various methods for preparing φ,φ_carotene-3,3'-diol by fermentation are illustrated in this document. These methods typically have very low space/time yields. In addition, in order to separate the pure formula; [pigment, which requires very complicated purification operations, makes it difficult to achieve an industrially economical implementation (j. Ind. Microbiol. Biotechnol. 243 15 64-70 (2000); Riv. Zootec .

Vet· 1974,1, 31-44; Phytochemistry 22,11,207-210, 1983)。為製備純淨的式1之(1),〇_胡蘿蔔素_3,3,_二醇,可選 擇總化學合成路徑。 德國專利第1593440號闡釋了式,扣胡蘿蔔素_3,3,·二 121373.doc 200811095 醇之合成。在此合成之結束階段,根據下文反應圖,使藏 花酸二醛1與兩當量鱗鹽2按照合成策略c1G + C2G + (:1〇以 雙重魏悌希(Wittig)烯化得到式I之Φ,Φ-胡蘿蔔素_3,3,_二 醇。Vet. 1974, 1, 31-44; Phytochemistry 22, 11, 207-210, 1983). To prepare the pure formula (1), 〇_carotene _3,3, diol, a total chemical synthesis route can be selected. German Patent No. 1593440 illustrates the synthesis of alcohols with carotenoids _3,3,·2 121373.doc 200811095. At the end of this synthesis, according to the reaction diagram below, crocetin dialdehyde 1 and two equivalents of scale salt 2 are olefinated according to the synthetic strategy c1G + C2G + (:1〇 by double Wittig) to obtain Φ of formula I, Φ-carotene _3,3,_diol.

R=四氫吡喃基 保護基團 1·魏悌希反應 2.消去保護基團 Φ,Φ-胡蘿蔔素-3,3*-二醇 根據德國專利弟1 5 9 3 4 4 0號’實例2,自2 5 8克(8 7 2毫莫 耳)式1之一酸消去保護基團後僅獲得1 ·5克式I之φ,φ·胡蘿 蔔素_3,3’-二醇(2.68毫莫耳=理論值之3〇·7〇/〇)。 此合成需要的式2之鱗鹽係自式η之2,3,6_三甲基·4·經基 本甲終按四階4又順序製備。根據德國專利第De_ 1593440 號,實例1,14.6克(89.02毫莫耳)式11之醛僅製得64克 (11.13¾莫耳)式2之鱗鹽。此產率亦不令人滿意。R = tetrahydropyranyl protecting group 1 · Wei Weixi reaction 2. Elimination of protecting group Φ, Φ-carotene-3, 3*-diol according to German Patent Brother 1 5 9 3 4 4 'Example 2, After removing the protecting group from 2 5 8 g (8 7 2 mmol) of the acid of formula 1, only 1.5 g of φ of formula I, φ carotene _3,3'-diol (2.68 mmol) was obtained. Ear = theoretical value of 3 〇 · 7 〇 / 〇). The scale salt of the formula 2 required for this synthesis is prepared from the 2,3,6-trimethyl·4· group of the formula η by the fourth order and the fourth order. According to German Patent No. 1593440, Example 1, 14.6 g (89.02 mmol) of the aldehyde of Formula 11 produced only 64 g (11.133⁄4 mol) of the scale salt of Formula 2. This yield is also unsatisfactory.

KJ -KJ -

四氫吡喃基 保護基團 理論值之12.5% R( 【發明内容】Tetrahydropyranyl protecting group 12.5% of theoretical value R (Invention content)

121373.doc 200811095 桌素-3,3 ’ -二醇之薪Γ、+ <新頭方法提供新穎中間體。 【實施方式】 此目的藉由製備式1之3,3,·二經基異二十二碳烯撑二偏 三曱基苯之方法達成,121373.doc 200811095 The tabletop-3,3'-diol salaries, + < new head method provides novel intermediates. [Embodiment] This object is achieved by the method for preparing 3,3,·di-diisoisodocesenedimetatriphenylbenzene of the formula 1,

ΟΗ 其包括至少下列步驟之一: a)使式II之單縮酮ΟΗ It includes at least one of the following steps: a) making a single ketal of formula II

其中’基團R係相同或不同,較佳係相同#,且係Ci_C8_ 烷基基團,或兩個基團R1共同係雙鍵結之C2_Ci2_伸烷基基 團亦即共同與其連接之原子形成環狀縮酮,尤其是5_或 6-元環縮酮; 與式Ilia或Illb之金屬化炔烴反應:Wherein the 'group R' is the same or different, preferably the same #, and is a Ci_C8_ alkyl group, or the two groups R1 are commonly double-bonded C2_Ci2_alkylene groups, ie, atoms bonded thereto Forming a cyclic ketal, especially a 5- or 6-membered cyclic ketal; reacting with a metallated alkyne of the formula Ilia or 111b:

其中’R係可藉由水解轉化為經基基團之醚、甲石夕烧基醚 或縮醛保護基團及Μι係Li、Na、κ、MgC卜MgBr、吨工或Wherein the 'R system can be converted into a group-containing ether, a methacrylate or an acetal protecting group by hydrolysis, and a lanthanum Li, Na, κ, MgC, MgBr, ton or

Mgm,式mb之化合物可為E同分異構體、z同分異構體或 E/Z同分異構體之混合物, 121373.doc 200811095 以形成式IVa或IVb之C15結構單元,Mgm, a compound of formula mb may be a mixture of E isomers, z isomers or E/Z isomers, 121373.doc 200811095 to form a C15 building block of formula IVa or IVb,

若適宜,繼而藉由使式IVa或Ivb2Cl5結構單元與還原 劑、尤其與複合物氫化鋁反應將三鍵轉化為雙鍵,得到式 IVa’或IVb’之C15結構單元,If appropriate, the C15 structural unit of the formula IVa' or IVb' is obtained by reacting a structural unit of the formula IVa or Ivb2Cl5 with a reducing agent, in particular with a complex of aluminum hydride, to convert the triple bond to a double bond.

b)藉由水解消去式IVa、m、…,或則,之CM結構單元 之保*蒦基團,得到式V4Vb之去保護之C15結構單元,b) deprotecting the C15 structural unit of the formula V4Vb by hydrolysis to eliminate the protecting group of the CM structural unit of the formula IVa, m, ..., or

Vb 繼而引入可藉 VIb之 C15 顯I, 由水解消去之〇H保護基團 ,得到式Via或Vb is then introduced by the C15 of the VIb, and the H protecting group is removed by hydrolysis to obtain the formula Via or

ViaVia

Vlb 其中 Y係 一—或 及 121373.doc 200811095 R2係可藉由水解轉化為羥基基團之醚、曱矽烷基醚或縮 醛保護基團, c)藉由還原羰基基團使式Via或VIb之C15酮反應為式Vila 或Vllb之二級C15醇,Vlb wherein Y is 1- or and 121373.doc 200811095 R2 is an ether, decyl ether or acetal protecting group which can be converted to a hydroxyl group by hydrolysis, c) by reducing a carbonyl group to give a formula Via or VIb The C15 ketone is reacted as a secondary C15 alcohol of the formula Vila or Vllb,

其中Y及R2係如步驟b)中之式via中所定義, d)使式Vila或Vllb之二級醇與強有機或無機酸Ηχ及與 二芳基膦Ρ(芳基)3反應,X係酸Ηχ之陰離子且芳基係 經取代或未經取代之芳基基團,經過式¥111&或 Vlllb之可分離中間體c15苯酚,Wherein Y and R2 are as defined in the formula via) in step b), d) reacting a secondary alcohol of the formula Vila or Vllb with a strong organic or inorganic acid and with a diarylphosphonium (aryl) 3, X An anion of an acid hydrazine and an aryl group which is substituted or unsubstituted, and an intermediate C15 phenol which can be isolated by the formula of 111 & or Vlllb

R3係OH或R2,且R 及Y係如步驟b)中之式via中所定 得到式IX或IX’之Cl5鱗鹽,R3 is OH or R2, and R and Y are as defined in step b), wherein the Cl5 scale salt of formula IX or IX' is obtained.

使式IX之C15鱗鹽與式X之2 式IX之C15鱗鹽同樣可藉由之c15鱗鹽, e)使式IX之C15鎖骧你j … 二鍵之部分氫化轉化為式Ιχ ,7·二甲基辛-2,4,6_三烯 121373.doc •10- 200811095The C15 scale salt of the formula IX can be similar to the C15 scale salt of the formula X IX by the c15 scale salt, e) the C15 of the formula IX is locked, and the partial hydrogenation of the second bond is converted into the formula Ιχ, 7 ·Dimethyl osin-2,4,6-triene 121373.doc •10- 200811095

以雙重魏悌希(Wittig)反應方式反應得到式I之化合物, 該等式 IVb、IVb,、Vb、VIb、Vllb、Vlllb、XI 及 IX’之化 合物可為E同分異構體、Z同分異構體或E/Z同分異構體之 混合物。 較佳地,在製備φ,φ-胡蘿蔔素-3,3,-二醇之本發明方法 中,至少實施步驟d),尤佳地,至少實施步驟d)及e),尤 其是實施步驟a)、b)、c)、d)及e)。 在本發明方法之步驟a)中,將式Π之單縮酮:The compound of formula I is obtained by a double Wittig reaction, and the compounds of the formulas IVb, IVb, Vb, VIb, V11b, Vlllb, XI and IX' may be E isomers, Z is isoforms. A mixture of constructs or E/Z isomers. Preferably, in the process of the invention for the preparation of φ,φ-carotene-3,3,-diol, at least step d) is carried out, and particularly preferably steps d) and e) are carried out, in particular step a ), b), c), d) and e). In step a) of the process of the invention, a monoketal of the formula:

其中’ R1基團係相同或不同’尤其是㈣,且係。丨_。8_烷 基基團,尤其是Ci_C4_烷基基團,例如甲基、乙基、正丙 基或正丁基,或該等兩個基團R1共同係雙鍵結2C2-Cl2-伸 烷基基團’尤其是C2_C8_伸烷基基團,亦即共同與其連接 之原子形成環狀縮酮’尤其是5_或6_員環縮酮,例如、,Wherein the 'R1 groups are the same or different', especially (four), and are.丨_. An alkyl group, especially a Ci_C4_alkyl group, such as methyl, ethyl, n-propyl or n-butyl, or the two groups R1 are a double bond 2C2-Cl2-alkylene a radical ', especially a C2_C8_alkylene group, that is, a ring that is attached thereto to form a cyclic ketal, especially a 5- or 6-membered cyclic ketal, for example,

乙 R4、R5或R6彼此獨立係氫或Ci_C4_炫基,例如甲基 土正丙基或正丁基,尤其是環狀縮酮 121373.doc 200811095B R4, R5 or R6 are independently hydrogen or Ci_C4_ danyl, such as methyl propyl or n-butyl, especially cyclic ketals. 121373.doc 200811095

Me 與式III a或Illb之金屬化炔烴反應Reaction of Me with a metal alkyne of formula III a or 111b

ma m 較佳係式Ilia之金屬化炔烴, 其中,R2係可藉由水解轉化為羥基基團之醚、甲矽烷基醚 或縮醛保護基團,尤其係Ma m is preferably a metallated alkyne of the formula Ilia, wherein the R2 is an ether, a methyl hydroxyalkyl ether or an acetal protecting group which can be converted to a hydroxyl group by hydrolysis, in particular

且 M1 係 Li、Na、K、MgCl、MgBr、Mgl 或 Mgi/2,尤佳 係Li、Na、MgCl或MgBr,極佳係Li,式Illb之化合物可為 E同分異構體、Z同分異構體或E/Z同分異構體之混合物, 得到式IVa或IVb、且較佳係IVa之C15結構單元,And M1 is Li, Na, K, MgCl, MgBr, Mgl or Mgi/2, especially Li, Na, MgCl or MgBr, excellent Li, the compound of formula 111b can be E isomer, Z is the same a mixture of isomers or E/Z isomers to give C15 structural units of formula IVa or IVb, and preferably IVa,

若適宜,繼而藉由使式IVa或IVbiCu結構單元與還原 劑(具體而s與複合物氮化紹’例如,氮化裡紹、二異丁 基氫化鋁及雙(2-甲氧基乙氧基)二氫化鈉鋁)反應將三鍵轉 化為雙鍵,形成式IVa’或IVb,且較佳係iva,之C”結構單 元, 121373.doc •12- 200811095If appropriate, by means of a structural unit of formula IVa or IVbiCu with a reducing agent (specifically, s and complexes are nitrided), for example, rivastigmine, diisobutylaluminum hydride and bis(2-methoxyethoxyl) The reaction of the sodium sulphate) converts the triple bond to a double bond to form the formula IVa' or IVb, and is preferably iva, the C" structural unit, 121373.doc • 12- 200811095

步驟a)中所用式η之單縮酮可以已知方式(zh. 〇rg. Khim· 26, 5,第 1087_1091頁;199〇。英譯第 936 94〇 頁, 1990)自已知原料式χι之2,3,5_三曱基苯醌(mimannsThe monoketal of the formula η used in the step a) can be known in a known manner (zh. 〇rg. Khim. 26, 5, pp. 1087_1091; 199 〇. English translation, 936 94 ,, 1990). 2,3,5_trimercaptobenzoquinone (mimanns

Encyclopedia 〇f industrial Chemistry,第 A 27卷,第 485Encyclopedia 〇f industrial Chemistry, Volume A, Volume 485

頁;1969)製備。Page; 1969) Preparation.

較佳地’在步驟a)中使用式114或11讣之環狀單縮酮。Preferably, the cyclic monoketal of formula 114 or 11 is used in step a).

其中R4、R5或R6彼此獨立係氫或Cl_C4_烷基,尤其是式π-a-1或ΙΙ-b-l之单縮嗣Wherein R4, R5 or R6 are independently hydrogen or Cl_C4_alkyl, especially a single enthalpy of the formula π-a-1 or ΙΙ-b-l

ΙΙΦ-1 式Ilia及式Illb之金屬化炔烴可自已知式ma_a(歐洲專利 第63325 8號)及1111)-1)(歐洲專利第5748號)之炔烴得到, 121373.doc -13- 200811095金属Φ-1 The metallated alkyne of the formula Ilia and the formula Illb can be obtained from an alkyne of the known formula ma_a (European Patent No. 63325 8) and 1111)-1) (European Patent No. 5748), 121373.doc -13- 200811095

其中,R2係可藉由水解轉化為羥基基團之醚、甲矽烷基 醚或縮醛保護基團,較佳係Wherein R2 is an ether, a methyl hydroxyalkyl ether or an acetal protecting group which can be converted into a hydroxyl group by hydrolysis, preferably

尤佳係 較佳地,在方法步驟a)中,原料係式IIIa-a之炔烴。 吾人大體上已知式Π-b-l之單縮酮中之羰基基團與炔丙 醇之乙炔化作用(Zh· Org. Khim. 27,7,第 1423-1428 頁, 1991 ;英譯第 1245-1249 頁,1992; Zh· Org. Khim. 26, 5,第 1087-1091 頁,1990; J. Org. Chem. USSR (英譯)ΕΝ 26, 936-940, 1990) ° 例如,未經保護之炔丙醇3-甲基戊-4-烯-1-炔-3-醇More preferably, in process step a), the starting material is an alkyne of formula IIIa-a. We generally know the acetylation of a carbonyl group in a monoketal of the formula Π-bl with propargyl alcohol (Zh· Org. Khim. 27, 7, pp. 1423-1428, 1991; English translation 1245- Page 1249, 1992; Zh· Org. Khim. 26, 5, pp. 1087-1091, 1990; J. Org. Chem. USSR (English translation) ΕΝ 26, 936-940, 1990) ° For example, unprotected Propargyl 3-methylpent-4-en-1-yn-3-ol

用2當量乙基溴化鎂金屬化後添加至式ΙΙ-b-l之單縮酮 中。所得式Vila之二醇之產率係理論值之68%(J. Org. Chem. USSR,ΕΝ 26,第 936 頁及其後;1990)。 121373.doc -14· 200811095After metallization with 2 equivalents of ethylmagnesium bromide, it was added to the monoketal of the formula ΙΙ-b-1. The yield of the resulting diol of the formula Vila is 68% of theory (J. Org. Chem. USSR, ΕΝ 26, p. 936 et s; 1990). 121373.doc -14· 200811095

類似地,式IIIb-b-OH之一級炔丙醇3-甲基戊·3-稀-1-炔 5-醇 ΗSimilarly, a formula IIIb-b-OH, a grade of propargyl alcohol, 3-methylpenta-3-di-1-ynyl 5-alcohol

lllb-b-OH 以3 8%之產率轉化為式¥111)之二醇(211.0巧.〖111111.27,7, 第1423頁及其後;1991,英譯第1245頁及其後;1992)。The lllb-b-OH is converted to the diol of the formula ¥111) in a yield of 38% (211.0 Qiao. [111111.27, 7, page 1423 and thereafter; 1991, English translation, page 1245 and later; 1992) .

0H 式Va-a及Vb-b之醌醇可藉由縮酮保護基團之水解自Vila 及Vllb獲得。0H The sterols of the formula Va-a and Vb-b can be obtained from the hydrolysis of the ketal protecting group from Vila and Vllb.

在本發明方法中,在式II之單縮酮炔基化中使用式IIIa-a 或IIIb-b經保護之炔丙醇(按照方法步驟a))可達成明顯提高 之產率。例如,在該加成反應中,以超過90%之產率獲得 式IVa及IVb之產物。 121373.doc -15- 200811095 車乂U也在步驟a)中,使式之單縮_與式心之金In the process of the invention, the use of a protected propargyl alcohol of formula IIIa-a or IIIb-b (according to process step a)) in the monoketal alkynylation of formula II provides a substantially improved yield. For example, in the addition reaction, the products of the formulae IVa and IVb are obtained in a yield of more than 90%. 121373.doc -15- 200811095 The rut U is also in step a), making the single shrink _ and the heart of the heart

為對式Π之單縮酮實施加成,藉由使式Illa-a及IIIb-b之 炔烴與鹼金屬或鹼土金屬醯胺、氫化物、有機鋰或格式 (Grignard)試劑在惰性溶劑(例如,開鏈或環狀醚或烴)中反 應而轉化為相應的式IIIa或IIIb之金屬化炔烴。對於快烴去 質子化而言,尤佳之鹼係醯胺鋰或有機鋰,此處尤佳係丁 基鋰。式IIIa-a或IIIb-b之金屬化炔烴與式π之單縮酮之莫 耳比通常係介於1:1與1.5:1之間,較佳係介於與ι.3:1 之間。過量之炔烴可藉由蒸餾自IVa或IVb分離出來且再循 環至合成中。 利用還原劑將式IVa或IVbiCw結構單元中的三鍵轉化 為雙鍵,得到式IVa’或IVb’iC”結構單元。原則上,還原 劑可使用所述用於炔丙醇還原之複合物氫化鋁,尤其氮化 經鋁、二異丁基氫化鋁及雙(2-曱氧基乙氧基)二氫化納叙 (Helv_ Chim· Acta 73,868,1990)。還原係在惰性環狀或開 鏈醚(二乙醚、曱基第三丁基醚、THF)或開鏈或環狀烴例 如己烧或甲苯中進行。 121373.doc -16- 200811095 尤佳地,將式IVa-liCb結構單元還原得到式IVaM之 C15結構單元。In order to carry out the addition of a monoketal of the formula 藉 by using the alkyne of the formulae 11a-a and IIIb-b with an alkali metal or alkaline earth metal decylamine, hydride, organolithium or format (Grignard) reagent in an inert solvent ( For example, an open chain or cyclic ether or a hydrocarbon) is converted to the corresponding metallated alkyne of formula IIIa or IIIb. For the rapid deprotonation of hydrocarbons, it is preferred that the base is lithium amide or organic lithium, and particularly preferred herein is butyl lithium. The molar ratio of the metallated alkyne of formula IIIa-a or IIIb-b to the monoketal of formula π is typically between 1:1 and 1.5:1, preferably between ι and 3:1. between. Excess alkyne can be separated from IVa or IVb by distillation and recycled to the synthesis. The triple bond in the structural unit of formula IVa or IVbiCw is converted to a double bond by means of a reducing agent to give a structural unit of the formula IVa' or IVb'iC". In principle, the reducing agent can be hydrogenated using the complex for the reduction of propargyl alcohol. Aluminium, especially nitrided by aluminum, diisobutylaluminum hydride and bis(2-decyloxyethoxy)dihydrocarbazide (Helv_Chim·Acta 73, 868, 1990). The reduction is in an inert ring or open The chain ether (diethyl ether, decyl tert-butyl ether, THF) or an open chain or cyclic hydrocarbon such as hexane or toluene is carried out. 121373.doc -16- 200811095 More preferably, the structural unit of the formula IVa-liCb is reduced. The C15 structural unit of formula IVaM is obtained.

在方法步驟b)中,藉由水解,纟其係酸水解消去式In process step b), by hydrolysis, hydrazine acid hydrolysis elimination

lva、Wb、lva,或lvb,之c15結構單元的保護基團得到去保 護之式Va或Vb2Cls結構單元,Lva, Wb, lva, or lvb, the protecting group of the c15 structural unit is deprotected by the Va or Vb2Cls structural unit,

Vb 繼而引入可藉由水解消去 π u上 w巧太之〇H保濩基團,得到式iVa或 IVb之 C15 酮,Vb is then introduced to remove the C15 ketone of formula iVa or IVb by hydrolysis to eliminate the oxime group of π u

/ I. 其中 Y 係 一CH—CH一 sfe 及 R係可藉由水解轉化為經基基B1 t ^、曱石夕烧基轉或縮 酸保護基團,較佳係 尤佳係/ I. wherein Y is a CH-CH-sfe and R-series can be converted to a base group B1 t ^, a ruthenium group or a carboxylic acid protecting group by hydrolysis, preferably a system

or

121373.doc 0 200811095 通常,在水及催化量強酸之存在下於惰性溶劑中進行式 IVa、IVb、IVa’或IVb’之C15結構單元中對酮官能基之保護 基團的水解及經保護羥基官能基之水解兩者以得到去保護 之式Va或Vb之C15結構單元。適宜溶劑係可與水混溶或不 混溶之惰性溶劑,例如開鏈或環狀醚,例如二乙醚、甲基 • 第三丁基醚、THF或二氧雜環己烷;以及烴,例如己烷、 . 庚烷、苯、曱苯或二曱苯;以及鹵代烴,例如二氣甲烷、 氣仿、1,2-二氯乙烷、1,2-二氣丙烷、氯苯等。酸可使用 ' 無機酸,例如,硫酸、氫氯酸或氫溴酸或磷酸,且亦可使 用強有機酸,例如甲烷-、苯-或甲苯磺酸以及甲酸、檸檬 酸或三氟乙酸。 令熟習此項技術者驚奇的是,在式IVa’或IVb’之C15結構 單元的情況下,儘管沒有對烯丙醇具有穩定作用之C-C三 鍵,但是在酸性反應條件下,無重排或消去發生。 較佳地,式IVa’-l之C15結構單元去保護得到式Va’-a之 C15結構單元。 k /121373.doc 0 200811095 In general, the hydrolysis of a protecting group for a ketone functional group in a C15 building block of formula IVa, IVb, IVa' or IVb' in an inert solvent in the presence of water and a catalytically strong acid and protected hydroxy group Both of the functional groups are hydrolyzed to give a C15 structural unit of the deprotected formula Va or Vb. Suitable solvents are inert solvents which are miscible or immiscible with water, such as open chain or cyclic ethers, such as diethyl ether, methyl • tert-butyl ether, THF or dioxane; and hydrocarbons, for example Hexane, heptane, benzene, toluene or diphenyl; and halogenated hydrocarbons such as di-methane, gas, 1,2-dichloroethane, 1,2-dipropane, chlorobenzene, and the like. As the acid, an inorganic acid such as sulfuric acid, hydrochloric acid or hydrobromic acid or phosphoric acid may be used, and a strong organic acid such as methane-, benzene- or toluenesulfonic acid and formic acid, citric acid or trifluoroacetic acid may also be used. Surprisingly skilled in the art, in the case of the C15 structural unit of formula IVa' or IVb', although there is no CC triple bond which has a stabilizing effect on allyl alcohol, there is no rearrangement under acidic reaction conditions. Elimination occurs. Preferably, the C15 building block of formula IVa'-1 deprotects the C15 building block of formula Va'-a. k /

式Va或Vb之C15結構單元中游離OH基團之保護產生式 Via或 VIb之 C15 酮。 根據自文獻(參見例如,H_ Stalder; Synthesemethoden der organischen Chemie [Synthesis methods in organic chemistry]; the Schweizerische Laboratoriums-Zeitschrift單 121373.doc -18 - 200811095 獨印刷,·第一版,1978年版 團0 1978年版權)得知 之方法W入保護基 15結構單元藉由添加兩當量乙 較佳地,式Va之去保護Cl5詞 烯基乙_轉化為式Via之C15酮,Protection of the free OH group in the C15 building block of formula Va or Vb produces a C15 ketone of the formula Via or VIb. According to the self-document (see, for example, H_ Stalder; Synthesemethoden der organischen Chemie [Synthesis methods in organic chemistry]; the Schweizerische Laboratoriums-Zeitschrift single 121373.doc -18 - 200811095 alone, · first edition, 1978 edition group 0 1978 copyright Knowing the method W into the protecting group 15 structural unit by adding two equivalents of B, preferably the formula Va to protect the Cl5 word alkenyl B - converted to the C15 ketone of the formula Via,

其中 Y 係一—或.一,且 R2係 _0-CH(Me)-〇-CH2CH3。 在方法步驟C)中,藉由還原羰基基團將VIa或vib之^15酮 轉化為式Vila或vilb之二級c15醇,Wherein Y is 1- or .-, and R2 is _0-CH(Me)-〇-CH2CH3. In method step C), the ketone of VIa or vib is converted to the secondary c15 alcohol of the formula Vila or vilb by reduction of the carbonyl group,

Y及R2係如步驟b)中之式via中所定義。 對於該步驟,原則上所有可將酮基基團還原為醇之氫化 物還原劑皆係適宜的,例如,複合物氫化硼及氫化鋁,例 如,硼氫化鈉、氫化鋰鋁、二異丁基氫化鋁及雙甲氧基 乙氧基)二氫化鈉鋁。 尤佳地,藉由還原將Via之C15酮轉化為式Vila之二級C15 醇,Y and R2 are as defined in the formula via in step b). For this step, in principle all hydride reducing agents which reduce the keto group to an alcohol are suitable, for example, the complexes of boron hydride and aluminum hydride, for example sodium borohydride, lithium aluminum hydride, diisobutylene Aluminum hydride and aluminum bis ethoxyethoxy) aluminium hydride. More preferably, the conversion of the C15 ketone of Via to the secondary C15 alcohol of the formula Vila is carried out by reduction,

VltaVlta

HO 121373.doc •19- 200811095 其中Y係—CH=CH_或一C三C—,且 R2係-0-CH(Me)_0-CH2CH3。 較佳地,在製備Φ,Φ-胡蘿蔔素-3,3’-二醇之本發明方法 中,在步驟c)中使用方法步驟b)中產生之式Via或VIb之C15 酮(未經分離且未經進一步處理)來製備式Vila或Vllb之二 級C15醇。HO 121373.doc •19- 200811095 wherein Y is -CH=CH_ or one C tri C-, and R2 is-0-CH(Me)_0-CH2CH3. Preferably, in the process of the invention for the preparation of Φ, Φ-carotene-3,3'-diol, the C15 ketone of the formula Via or VIb produced in process step b) is used in step c) (un-isolated) And without further treatment) to prepare a secondary C15 alcohol of the formula Vila or Vllb.

在方法步驟d)中,使式Vila或Vllb之二級Cls醇與強有機 或無機酸HX及與三芳基膦p(芳基係酸HX之陰離子且 芳基係經取代或未經取代之C6-C14-芳基基團)反應,經由 式Villa或Vlllb之可分離中間體c15苯酚,In process step d), a secondary Cls alcohol of the formula Vila or Vllb is combined with a strong organic or inorganic acid HX and with a triarylphosphine p (an anion of the aryl acid HX and an aryl substituted or unsubstituted C6) -C14-aryl group) reaction, the intermediate c15 phenol can be separated via the formula Villa or Vlllb,

3 乂 R係OH或R2,且R2及Y係如步驟b)中之式VIa中所定 義,3 乂 R is OH or R2, and R2 and Y are as defined in formula VIa in step b),

得到式IX或IX,之Cl5鱗鹽,Obtaining Cl5 scale salt of formula IX or IX,

式鱗鹽同樣可藉由三鍵部分氫化轉化為式1:^之 C 1 5鱗鹽。 對於芳ί哀化作用,使式VIIa4VIIb之二級C15醇經受消去 OH保護基團且女、甘 > ® 尤其級党酸催化縮醛水解之反應條件。 121373.doc -20- 200811095 強有機或無機酸意指其pKas小於3、較佳小於1之彼等 酉文。強有機或無機酸之實例係氫鹵酸(例如氫氣酸、氫演 酉文或氫硬酸)、磺酸(例如甲烷石黃酸、對·甲苯石黃酸或三氟甲 烷磺酸)、或三鹵代乙酸(例如三氟乙酸或三氯乙酸)。 在三芳基膦P(芳基)3中,該等芳基基團不僅可係經取代 的且亦可係未經取代的CrCw-芳基,較佳係〇6_〇1()_芳基基 團’尤其係苯基。芳基基團上之取代基可為(例如)_素及/ 或K〗2 ’尤其係CrCV烧基基團,例如甲基、乙基、丙 基或丁基。較佳地,在方法步驟d)中,使用三苯基膦作為 二方基膦P(芳基)3。 吾人原則上已知醌醇系統之酸催化芳環化作用(Zh. 〇rg.The scaly salt can also be converted to a C 1 5 scale salt of the formula 1: by partial hydrogenation of a triple bond. For the aryl liberation, the secondary C15 alcohol of the formula VIIa4VIIb is subjected to a reaction condition which eliminates the OH protecting group and the female, gans > 121373.doc -20- 200811095 Strong organic or inorganic acid means those whose pKas are less than 3, preferably less than 1. Examples of strong organic or inorganic acids are hydrohalic acids (such as hydrogen acid, hydrogen or hydrogen sulphuric acid), sulphonic acids (such as methanelithic acid, p-toluene or trifluoromethanesulfonic acid), or Trihaloacetic acid (e.g., trifluoroacetic acid or trichloroacetic acid). In the triarylphosphine P(aryl) 3, the aryl groups may be not only substituted but also unsubstituted CrCw-aryl groups, preferably 〇6_〇1()_aryl group The group 'is especially phenyl. The substituent on the aryl group may be, for example, _ and/or K "> 2 ' especially a CrCV alkyl group such as methyl, ethyl, propyl or butyl. Preferably, in process step d), triphenylphosphine is used as the diarylphosphine P(aryl)3. In principle, we know the acid-catalyzed aromatic cyclization of the sterol system (Zh. 〇rg.

Khim· 27,12,第2588頁及其後,1991,英譯第2305頁及 其後;1992)。但是,在文獻中此係始於環上之游離三級 醇而非其經保護形式,例如縮酸。另外,該底物不包含其 他烯丙基醇或縮醛基團。Khim, 27, 12, p. 2588 et seq., 1991, English translation, p. 2305 and thereafter; 1992). However, in the literature this is the free tertiary alcohol starting from the ring rather than its protected form, such as the acid. Additionally, the substrate does not contain other allyl alcohol or acetal groups.

在酸催化縮醛消去條件下對式Vila或Vllb之二級C15醇 (尤其式Vila之二級C15醇,其中R2係-〇-CH(Me)-〇-CH2CH3)之處理中,烯丙基醇官能基仍係完好的。此結果 係令人驚奇的,乃因熟習此項技術者原本預計會發生水消 去或在第二烯丙基OH基團上發生重排。 121373.doc •21 · 200811095 尤其令人驚奇的是’在強酸及三苯基膦存在下,即在鱗 鹽形成條件下,從式Vila或vilb之二級Cl5醇開始,可經一 個步驟直接到達式IX或IX,之鎸鹽,該反應經由式VIIIa或 Vlllb之可分離中間體。 較佳地,在方法步驟d)中,在式villa或Vlllb之二級c15 醇至式IX或IXAC"鎸鹽的反應中,強酸HX使用氫溴酸或 氫氯酸且三芳基膦P(芳基)3使用三苯基膦。 用於將式Vila或Vilb之二級C15醇直接轉化為式ΐχ*ΙΧ, 之Cls鱗鹽之較佳試劑使用三芳基膦_ΗΧ加成物ρ(芳 基)3*ΗΧ,尤其係三苯基膦氫氣酸鹽或三苯基膦氫溴酸 鹽〇 在方法步驟d)之一尤佳實施例中,式Vila之二級C15醇,Treatment of a secondary C15 alcohol of the formula Vila or Vllb (especially a secondary C15 alcohol of the formula Vila, wherein R2 is -〇-CH(Me)-〇-CH2CH3) under acid-catalyzed acetal elimination conditions, allyl The alcohol functional group is still intact. This result is surprising because those skilled in the art would have expected water to be eliminated or rearranged on the second allyl OH group. 121373.doc •21 · 200811095 It is especially surprising that 'in the presence of strong acid and triphenylphosphine, ie under the conditions of scale salt formation, starting from the secondary Cl5 alcohol of the formula Vila or vilb, can be reached directly in one step The hydrazine salt of formula IX or IX, the reaction is via the separable intermediate of formula VIIIa or V11lb. Preferably, in process step d), in the reaction of a secondary c15 alcohol of the formula villa or Vlllb to a salt of the formula IX or IXAC " sulfonium salt, the strong acid HX uses hydrobromic acid or hydrochloric acid and the triarylphosphine P (aryl) Base 3 uses triphenylphosphine. A preferred reagent for the direct conversion of a secondary C15 alcohol of the formula Vila or Vilb to a Cls scale salt of the formula 使用*ΙΧ, using a triarylphosphine-ruthenium adduct ρ(aryl) 3*ΗΧ, especially triphenyl a phosphinic acid hydrogenate or a triphenylphosphine hydrobromide hydrazine in a preferred embodiment of one of process steps d), a secondary C15 alcohol of the formula Vila,

γ 係 CH = CH —或一—且 R2係-0_CH(Me)-0-CH2CH3,係與三苯基膦氫溴酸鹽反 應得到式IX或IX’之C15鱗鹽。此處該反應經由作為中間體 之式VIIIa-a或VIIIa-b之C15苯酚,但是其無需以固體形式 分離。γ series CH = CH — or — — and R 2 —-0—CH(Me)-0-CH 2 CH 3 is reacted with triphenylphosphine hydrobromide to give a C15 scale salt of formula IX or IX'. Here, the reaction is carried out via C15 phenol of the formula VIIIa-a or VIIIa-b as an intermediate, but it does not need to be isolated as a solid.

IX 或 121373.doc -22- IX, 200811095 γ 係 CH==:CH —或 一c三c—,及 芳基係苯基且X係Br。 式IX’之炔鱗鹽中C-C三鍵部分氫化得到式IX之鎸鹽係如 文獻中所述達成(歐洲專利第100 839號)。 較佳地,在製備φ,φ-胡蘿蔔素-3,3’-二醇之本發明方法 之方法步驟d)中,式Villa或Vlllb之中間體未經分離,而 將式Vila或Vllb之二級C15醇直接轉化為式IX或IX,之C15鱗 鹽〇 在方法步驟a)、b)、c)、d)及e)中使用或獲得的式iVb、 IVbf、Vb、VIb、Vllb、Vlllb、XI及 IX,之化合物可以 E 同 分異構體、Z同分異構體或E/Z同分異構體之混合物存在。 在方法步驟e)中,使式IXiCw鱗鹽與2,7-二甲基辛_ 2,4,6-三烯二醛以雙重魏悌希反應反應得到式j之化合物。 式IX2C1S鎮鹽與先前未在文獻中闡述的式X之2,7-二甲 基辛-二浠一备之雙重魏悌希縮合可藉由大體上自關 於此製程之文獻得知之方法進行(參考文獻”Car〇ten〇ids, 第 2卷:Synthesis」,Birkhauser Verlag,:1996)。用於產生 内輪鹽之較佳驗係驗金屬或驗土金屬之c广c6-醇鹽,較佳 呈存於對應Ci-CV醇中之溶液,溶劑可使用氯化烴,例 如,二氯甲烷、1,2-二氣乙烷、l52-二氯丙烷或開鏈或環 狀醚。醚溶劑可使用(例如)四氫呋喃、二氧雜環己烷或乙 二醇醚。亦可使用含羥基醚,例如丨_甲氧基丙_2_醇或2_甲 氧基肉-1-醇。對於此反應,對應醇鹽之。<6_醇(單獨或 與上述溶劑之一組合)亦係適宜的。 121373.doc -23- 200811095 另一較佳實施例係藉助環氧乙烷作為”潛伏鹼」產生内 鏽鹽(Chem. Ber· 1〇7,第2〇50頁及其後(1974)),例如藉由 在式X之二醛存在下、於環氧乙烷(較佳係丨,2_環氧丁烷) 溶劑中加熱式1X2 Cls鱗鹽數小時。該反應可在純淨環氧 乙烷或在環氧乙烷與上述溶劑之一的混合物中進行。此處 可藉由過濾反應混合物而無需額外處理步驟分離出式I之 最終產物。 藉助兩個具體實例闌釋用於製備 •二醇之上述方法的若干方 在圖1及2中的各式中,: 式I之Φ,Φ-胡蘿蔔素_3,3,- 驟。 121373.doc -24- 200811095IX or 121373.doc -22- IX, 200811095 γ is CH==:CH — or a c 3 c—, and an aryl phenyl group and an X system Br. Partial hydrogenation of the C-C triple bond in the alkyne salt of formula IX' to give the phosphonium salt of formula IX is achieved as described in the literature (European Patent No. 100 839). Preferably, in the step d) of the process of the invention for the preparation of φ,φ-carotene-3,3'-diol, the intermediate of the formula Villa or Vlllb is not isolated, but the second of the formula Vila or Vllb Conversion of a C15 alcohol directly to Formula IX or IX, a C15 scale salt of the formula iVb, IVbf, Vb, VIb, Vllb, Vlllb used or obtained in process steps a), b), c), d) and e) The compounds of XI and IX may be present as a mixture of E isomers, Z isomers or E/Z isomers. In process step e), the sulfonium salt of the formula IXiCw is reacted with 2,7-dimethyloctyl 2,4,6-trienedialdehyde in a double Weiss reaction to give the compound of the formula j. The bismuth salt of the formula IX2C1S and the 2,7-dimethyloctyl-dioxime of the formula X previously not described in the literature can be carried out by a method substantially known from the literature on the process (Reference) "Car〇ten〇ids, Volume 2: Synthesis", Birkhauser Verlag, 1996). The c-C6-alkoxide of the metal or soil-measuring metal for producing the inner-wheel salt is preferably a solution in the corresponding Ci-CV alcohol, and the solvent may be a chlorinated hydrocarbon, for example, dichloromethane. 1,2-dioxaethane, l52-dichloropropane or an open chain or cyclic ether. As the ether solvent, for example, tetrahydrofuran, dioxane or ethylene glycol ether can be used. Hydroxy-containing ethers such as 丨-methoxyprop-2-ol or 2-methoxy-1-enol can also be used. For this reaction, it corresponds to the alkoxide. <6-alcohol (alone or in combination with one of the above solvents) is also suitable. 121373.doc -23- 200811095 Another preferred embodiment produces internal rust salts by means of ethylene oxide as a "latent base" (Chem. Ber. 〇7, p. 2, p. 50 et seq. (1974)), For example, the sulfonate salt of the formula 1X2 Cls is heated in the presence of a dialdehyde of the formula X in an ethylene oxide (preferably hydrazine, 2_butylene oxide) solvent for several hours. The reaction can be carried out in neat ethylene oxide or in a mixture of ethylene oxide and one of the above solvents. The final product of formula I can be isolated by filtering the reaction mixture without additional processing steps. Several examples of the above methods for preparing • diols are exemplified by two specific examples. In the formulas of Figures 1 and 2, Φ, Φ-carotene _3, 3, - 121373.doc -24- 200811095

121373.doc -25- 200811095 圖2121373.doc -25- 200811095 Figure 2

IVa^l Vla'-1IVa^l Vla'-1

但是在圖1中,C-C三鍵的選擇性氫化直至產生式IX’之 c15鱗鹽後才進行,而在圖2中,C-C三鍵係在式II之單縮酮 炔基化作用後直接選擇性還原為C-C雙鍵。 本發明進一步係關於式IVa或IVb之C15結構單元, 121373.doc -26- 200811095However, in Figure 1, the selective hydrogenation of the CC triple bond is carried out until the c15 scale salt of formula IX' is produced, while in Figure 2, the CC triple bond is directly selected after the monoketal alkyneization of formula II. Sexual reduction to CC double bond. The invention further relates to a C15 building block of formula IVa or IVb, 121373.doc -26- 200811095

其中基團R1及R2係以如上文在步驟a)中闡述之方式定義, 亦即其中R1係相同的或不同的,較佳係相同❸,且係Cl· 烷基基團,或兩個基團…共同係雙鍵結之C2-Ci2_伸烷 基基團,亦即共同與其連接之原子形成環狀縮酮,尤其是 %或6-員環縮酮,且r2係可藉由水解轉化為羥基基團之 醚、甲矽烷基醚或縮醛保護基團,且式lvb之ci5結構單元 可以E同分異構體、Z同分異構體或E/z同分異構體之混合 物存在。 尤佳者係式IVa2Cls結構單元,其與下式相同Wherein the groups R1 and R2 are defined in the manner as set forth above in step a), ie wherein R1 are the same or different, preferably the same oxime, and are a Cl. alkyl group, or two groups. The group is a double-bonded C2-Ci2_alkylene group, that is, a ring that is attached to it to form a cyclic ketal, especially a % or 6-membered cyclic ketal, and the r2 system can be converted by hydrolysis. Is an ether, a carboxyalkyl ether or an acetal protecting group of a hydroxyl group, and the ci5 structural unit of the formula lvb may be a mixture of an E isomer, a Z isomer or an E/z isomer. presence. Especially preferred is the structural unit of the formula IVa2Cls, which is the same as the following formula

本發明亦係關於式IVa’或IVb’之C15結構單元,The invention is also directed to a C15 building block of formula IVa' or IVb',

其中基團R1及R2係以如上文在步驟a)中闡述之方式定義, 亦即其中R1係相同的或不同的,較佳係不同的,且係CWherein the groups R1 and R2 are defined in the manner as set forth above in step a), ie wherein R1 is the same or different, preferably different, and is C

Cp烧基基團,或兩個基團R1共同係雙鍵结 、、’Ό 心 L2-C12-伸烧 121373.doc -27- 200811095 基基團,亦即共同與其連接之原子形成環狀縮酮,尤其是 5-或6-員環縮酮,且r2係可藉由水解轉化為羥基基團2 醚、甲矽烷基醚或縮醛保護基團,且式IVb,之Cm結構單元a Cp alkyl group, or two groups R1 are commonly a double bond, 'Ό心 L2-C12-Extensible 121373.doc -27- 200811095 base group, that is, the atoms connected to it form a ring-shaped shrinkage a ketone, especially a 5- or 6-membered cyclic ketal, and the r2 system can be converted to a hydroxy group 2 ether, a dimethyl ketone ether or an acetal protecting group by hydrolysis, and a Cm structural unit of the formula IVb

可為E同分異構體、z同分異構體或E/z同分異構體之混I 物。 尤佳者係式ΐνα,2(^5結構單元,其與下式相同It may be a mixture of E isomers, z isomers or E/z isomers. More preferred is the system ΐνα, 2 (^5 structural unit, which is the same as the following formula

此外’本發明進一步係關於式Va’-aiC^結構單元Further, the present invention further relates to the structural unit of the formula Va'-aiC^

本發明亦係關於式Via或VIb之C15酮,The invention also relates to a C15 ketone of the formula Via or VIb,

Vlb 其中Y及基團R2係以如上文在步驟b)中闡述之方式定義, 亦即其中Y係-CH=CH-或C-C三鍵,且R2係可藉由水解轉化 為羥基基團之醚、甲矽烷基醚或縮醛保護基團,且式VIb 之。1$酮可為e同分異構體、Z同分異構體或e/z同分異構體 之混合物。 尤佳者係式Via之C15酮,其中Y係-CH=CH-或C_C三鍵且 R2係-0-CH(Me)-0-CH2CH3。 121373.doc 200811095 本發明進一步係關於式Vila或Vllb之二級C15醇Vlb wherein Y and the group R2 are defined in the manner as set forth above in step b), that is, wherein the Y system is a CH-CH- or CC triple bond, and the R2 is an ether which can be converted to a hydroxyl group by hydrolysis. a formyl ether or acetal protecting group, and of formula VIb. The 1$ ketone may be a mixture of e isomers, Z isomers or e/z isomers. More preferably, the C15 ketone of Via is a Y-system-CH=CH- or C_C triple bond and R2 is a-0-CH(Me)-0-CH2CH3. 121373.doc 200811095 The invention further relates to a secondary C15 alcohol of the formula Vila or Vllb

其中,Y及R2亦係如式Via或VIb之C15_中所定義,亦即其 中Y係_CH=CH-或C-C三鍵,且R2係可藉由水解轉化為羥基 基團之醚、曱矽烷基醚或縮醛保護基團,且式Vllb之二級 C1S醇可為E同分異構體、Z同分異構體或E/Z同分異構體之 混合物。 尤佳者係式Vila之二級C15醇,其中R2係-0-CH(Me)-〇_ CH2CH3。 本發明亦係關於式Villa或Vlllb之C15苯酚,Wherein, Y and R2 are also as defined in C15_ of the formula Via or VIb, that is, wherein Y is a _CH=CH- or CC triple bond, and R2 is an ether or hydrazine which can be converted into a hydroxyl group by hydrolysis. A decyl ether or acetal protecting group, and the secondary C1S alcohol of formula V11b can be a mixture of E isomers, Z isomers or E/Z isomers. More preferred is a secondary C15 alcohol of the family Vila, wherein R2 is-0-CH(Me)-〇_CH2CH3. The invention also relates to C15 phenol of the formula Villa or Vlllb,

R3係OH或R2,且R2及Y係如在式VII中所述,且式Vlllb 之C15苯酚可為E同分異構體、Z同分異構體或E/Z同分異構 體之混合物。 尤佳者係式Villa之C15苯酚,其中R3係OH或-O-CH(Me)- o-ch2ch3 〇 本發明亦係關於式IX或IX’之c15鱗鹽,R3 is OH or R2, and R2 and Y are as described in formula VII, and the C15 phenol of formula V11lb may be an E isomer, a Z isomer or an E/Z isomer. mixture. More particularly preferred is C15 phenol of the family Villa, wherein R3 is OH or -O-CH(Me)-o-ch2ch3 〇 The present invention is also directed to c15 scale salts of formula IX or IX',

121373.doc -29- 200811095 其中,芳基及x係以如上文在步驟d)中闡述之方式定義, 亦即其中X係強有機或無機酸HX之陰離子且芳基係經取代 或未經取代之芳基基團,且式IX或IX,之c15鱗鹽可 為E同分異構體、Z同分異構體或E/Z同分異構體之混合 物。 較佳地,X係CI或Br且芳基係苯基。 本發明進一步係關於製備式IX之C15鱗鹽之方法,121373.doc -29- 200811095 wherein aryl and x are defined as described above in step d), ie an anion of the X-based strong organic or inorganic acid HX and the aryl is substituted or unsubstituted The aryl group, and the c15 scale salt of formula IX or IX, may be a mixture of E isomers, Z isomers or E/Z isomers. Preferably, X is CI or Br and the aryl is phenyl. The invention further relates to a process for preparing a C15 scale salt of formula IX,

其包括使式Vila或Vllb之二級C15醇It includes a secondary C15 alcohol of the formula Vila or Vllb

R2係可藉由水解轉化為羥基基團之醚、曱石夕烧基鱗或 縮酸保護基團,且 式Vllb之--級C15醇可為E同分異構體、z同分異構體 或E/Z同分異構體之混合物, 與強有機或無機酸HX及與三芳基膦p(芳基)3反應,χ係 酸HX之陰離子且尤其係C1或Br,且芳基係經取代或未經 取代之C6-Ci4-芳基基團,尤其係苯基, 以得到Cls鱗鹽,倘若以式Vila或Vllb為起始產物,其中 121373.doc -30- 200811095 Y係二鍵’该C 1 5鱗鹽之二餘» 、 之一鍵精由部分氫化轉化為雙鍵以到 達式1又之(^5鱗鹽,該式 飞认之匕5鱗鹽可為Ε同分異構體、Ζ 同分異構體或Ε/Ζ同分異構體之思合物。 本發明將藉由以下實例關成 果例閣这’但其非用於限定本發明。 一般細節:該等有機今屬仆 尸 機至屬化合物之製備及處理係在無空 氣及水分、於保護性氣體下進行。 實例1-式IVa-liCu結構單元之合成R2 can be converted to a hydroxyl group by ether, a sulfonium group or a acetylation protecting group, and the C15 alcohol of the formula V11b can be an E isomer, z isomer a mixture of a body or an E/Z isomer, reacting with a strong organic or inorganic acid HX and with a triarylphosphine p(aryl)3, an anion of the lanthanic acid HX and especially a C1 or Br, and an aryl system a substituted or unsubstituted C6-Ci4-aryl group, especially a phenyl group, to give a Cls scale salt, provided that the formula Vila or Vllb is the starting product, wherein 121373.doc -30- 200811095 Y is a two bond 'The C 1 5 scale salt of the two», one of the bonds is converted from a partial hydrogenation to a double bond to reach the formula 1 (^5 scale salt, the formula of the fly 匕5 scale salt can be different The present invention will be exemplified by the following examples, but it is not intended to limit the invention. General details: The preparation and treatment of organic compounds belonging to servants is carried out without air and moisture under protective gas. Example 1 - Synthesis of IVa-liCu structural units

ΒυϋΒυϋ

11各1 llla-a-1 在兩平订批料之每一者中,將1654克(〇961莫耳)式 IIIa+l之炔烴溶解在丨·48公升甲苯中。在(TC下,逐滴加 入335 ¾升正丁基鋰存於己烷中之2·5 μ溶液㈣·_莫耳11 each 1 llla-a-1 In each of the two batches, 1654 g (〇961 mol) of the alkyne of the formula IIIa+l was dissolved in 丨·48 liter of toluene. At (TC), add 335 3⁄4 liters of n-butyl lithium in hexane in 2.5 μl solution (tetra)·_mole

BuU),並將該混合物在〇。〇下擾掉3〇分鐘。隨後,逐滴加 入143.5克(0.739莫耳)式π-b-l之單縮酮存於3 7〇毫升甲苯 中之溶液並將該混合物在GtT再擾拌H、時。為了實施處 理注入370¾升冰水。將該混合物再充分授摔$分鐘並將 兩批料在刀液漏斗中合併。分離出底相且將頂相用37〇毫 升10%濃度的乙酸水溶液及水洗滌兩次。將頂相用硫酸鈉 乾燥。過濾出乾燥劑後,在旋轉蒸發器上於6〇<t下濃縮濾 液至10毫巴。在100 C加熱溫度及5_6毫巴真空下的薄膜蒸 發盗上藉由真空蒸餾分離出過量炔烴。此產生^^々克作 為薄膜蒸發器流出物之式!Va-kCi5結構單元;此對應於 121373.doc -31- 200811095 理論值之96%之產率(基於ΙΜ)_υ。根據氣相層析分析,該 產物具有97.7%之純度。 κ例2-式Va-a之C15結構單元之合成BuU) and the mixture is in the crucible. The armpits disturbed for 3 minutes. Subsequently, a solution of 143.5 g (0.739 mol) of a monoketal of the formula π-b-1 in 3 7 ml of toluene was added dropwise and the mixture was further scrambled with H at GtT. In order to carry out the treatment, 3,073⁄4 liters of ice water was injected. The mixture was again fully discarded for $ minutes and the two batches were combined in a knife funnel. The bottom phase was separated and the top phase was washed twice with 37 Torr of 10% aqueous acetic acid and water. The top phase was dried over sodium sulfate. After filtering off the desiccant, the filtrate was concentrated to 10 mbar at 6 Torr <t on a rotary evaporator. Excess alkyne was separated by vacuum distillation at a film evaporation temperature of 100 C heating temperature and a vacuum of 5-6 mbar. This produces ^^々克 as the thin film evaporator effluent! Va-kCi5 structural unit; this corresponds to a yield of 96% of the theoretical value of 121373.doc -31- 200811095 (based on ΙΜ)_υ. According to gas chromatography analysis, the product had a purity of 97.7%. Synthesis of C15 structural unit of κ-type 2-form Va-a

將35 9克(〇.989莫耳)來自實例1之式1〜_1之(^5結構單元 (97.7/。純度)洛解在990¾升四氫呋喃中。隨後,在2〇c>c至 25 C下加入178克(9·89莫耳)水及23 53克4〇%濃度的對-甲 苯磺酸單水合物之水溶液卜49·5毫莫耳,對_甲苯磺酸)。 將混合物在+5G°C下再授拌!小時。為了實施處理,將批料 用5公升甲基第二丁基醚稀釋。將有機相用丨公升飽和碳酸 氫鹽溶液洗滌一次且每次用丨公升水洗滌兩次並用硫酸鈉 乾燥。過濾出乾燥劑後,在旋轉蒸發器上於5(rc下濃縮濾 液至20毫巴。此產生236.6克99.1。/。純度(藉助氣相層析)之 作為殘留物的式Va-aiC"結構單元(理論值之97·3%)。為 更好純化,將產物自5 00毫升甲苯中重結晶。 此產生216克具有100%純度(藉助氣相層析)及ι〇6· 5它至 l〇7°C熔點之式Va-a之C15結構單元。 實例3-式VIa-Ι之C15酮之合成35 9 g (〇.989 mol) from formula 1 to _1 of Example 1 (^5 structural unit (97.7/. purity) was dissolved in 9903⁄4 liters of tetrahydrofuran. Subsequently, at 2〇c>c to 25 C Next, 178 g (9·89 mol) of water and 23 53 g of a 4% by weight aqueous solution of p-toluenesulfonic acid monohydrate were added in an amount of 49·5 mmol, p-toluenesulfonic acid. Mix the mixture at +5G °C! hour. To carry out the treatment, the batch was diluted with 5 liters of methyl second butyl ether. The organic phase was washed once with 丨 liter of saturated bicarbonate solution and washed twice with 丨 liters of water each time and dried over sodium sulfate. After filtering off the desiccant, the filtrate was concentrated to 20 mbar at 5 (rc) on a rotary evaporator. This gave 236.6 g of 99.1% purity (by gas chromatography) of the formula Va-aiC" Unit (97.3% of theory). For better purification, the product was recrystallized from 500 ml of toluene. This yielded 216 g with 100% purity (by gas chromatography) and ι〇6·5 to l C 7 ° C melting point of the formula Ca-a C15 structural unit. Example 3 - Formula VIa - Ι C15 ketone synthesis

將189.6克(0.77莫耳)來自實例2之式Va-a之C"結構單元 121373.doc -32- 200811095 ㈣T_44公升f苯中。加人11()克(5 78毫莫耳)對-甲苯 磧酸早水合物且然後在20。。至25它下經3〇分鐘逐滴加入 208.4克(2.89莫耳)乙稀基乙醚。再搜摔%分鐘後,再次加 入二0毫克(2.89毫莫耳)對_甲苯續酸單水合物且將混合物 在至'皿下再攪拌3小時。為了實施處理’加入190毫升飽和 石厌酉夂風鹽溶液且將混合物再劇烈㈣5分鐘。分離出水性 底=將有機頂相用19〇毫升飽和碳酸氫鈉溶液洗滌一次 且每人用8G毫升水洗務兩次。將有機相用硫酸納乾燥。過 慮出乾燥劑後’在旋轉蒸發器上於筑下濃縮滤液至5毫 巴此產生305·3克作為殘留物的式via_i之c15酮,將其作為 粗產物(無進一步純化)進一步處理。此粗產率係定量的。 實例4-式Vllaq之二級Ci5醇之合成189.6 g (0.77 mol) of the C" structural unit of the formula Va-a of Example 2 121373.doc -32- 200811095 (iv) T_44 liters of f benzene. Add 11 () grams (5 78 mmol) of p-toluene citrate early hydrate and then at 20. . To 25, 208.4 g (2.89 mol) of ethyl ether was added dropwise over 3 minutes. After a further minute drop, another 20 mg (2.89 mmol) of p-toluene acid monohydrate was added and the mixture was stirred for a further 3 hours under the dish. To carry out the treatment', 190 ml of saturated rock anaerobic salt solution was added and the mixture was vigorously vigorous (four) for 5 minutes. The aqueous bottom was separated = the organic top phase was washed once with 19 ml of saturated sodium bicarbonate solution and each person was washed twice with 8 g of water. The organic phase was dried over sodium sulfate. After the desiccant was taken into consideration, the filtrate was concentrated to 5 mbar on a rotary evaporator to give 305. 3 g of the c15 ketone of the formula via_i as a residue, which was further treated as a crude product (without further purification). This crude yield is quantitative. Example 4 - Synthesis of a secondary Ci5 alcohol of the formula Vllaq

在兩平行批料之每一者中,將152.6克(0.385莫耳,原樣 使用)來自實例3之式VIa-Ι之粗C15酮於室溫下溶解在154〇 毫升THF中。在〇°C下,經60分鐘注入120克已用1540毫升 本稀釋之雙(2-甲氧基乙氧基)二氫化納|呂之65%濃度的 甲苯溶液。將混合物在〇°C下再攪拌1小時。然後在〇°C下 逐滴加入77毫升乙醇與77毫升己烷之混合物,將混合物在 〇C下再攪拌15分鐘,在〇°C下逐滴加入77毫升15%濃度的 氣氧化納溶液並將混合物在0Ό下再攪拌15分鐘。將混合 121373.doc -33- 200811095 物在0°C下與144毫升水混合;將此混合物加熱至室溫並添 加320毫升正己烷。然後將該兩相混合物轉移至分液漏斗 中。分離出底相,將頂相每次用77毫升半濃縮之氯化鈉溶 液洗滌三次。將該合併之底相用甲苯再萃取一次。合併兩 批料之有機頂相、用硫酸鈉乾燥並在旋轉蒸發器上於+6〇 °C下濃縮濾液至5毫巴。此產生322.9克作為殘留物之式 VIIa-Ι之粗二級C15醇;藉助HPLC之純度為86.2% ;此對應 於理論值之92·2%(基於式Va-a之Cl5結構單元)。 實例5-式Villa-1之C15苯酚之合成In each of the two parallel batches, 152.6 g (0.385 mol, used as received) of the crude C15 ketone of Formula VIa-Ι from Example 3 was dissolved in 154 mL of THF at room temperature. At 〇 ° C, 120 g of a toluene solution having a concentration of 640 ml of this diluted bis(2-methoxyethoxy)dihydrocarbazide was used over 60 minutes. The mixture was stirred at 〇 ° C for an additional hour. Then, a mixture of 77 ml of ethanol and 77 ml of hexane was added dropwise at 〇 ° C, the mixture was further stirred at 〇 C for 15 minutes, and 77 ml of a 15% strength gas oxidized sodium solution was added dropwise at 〇 ° C. The mixture was stirred at 0 Torr for a further 15 minutes. The mixture 121373.doc -33- 200811095 was mixed with 144 ml of water at 0 ° C; the mixture was heated to room temperature and 320 ml of n-hexane was added. The two phase mixture was then transferred to a separatory funnel. The bottom phase was separated and the top phase was washed three times with 77 ml of a semi-concentrated sodium chloride solution each time. The combined bottom phase was extracted once more with toluene. The organic top phases of the two batches were combined, dried over sodium sulfate and the filtrate was concentrated to 5 mbar. This gave 322.9 g of crude crude C15 alcohol of formula VIIa-Ι as a residue; purity by HPLC was 86.2%; this corresponds to 92.2% of theory (based on Cl5 structural unit of formula Va-a). Example 5 - Synthesis of C15 phenol of Villa-1

將49.1克來自實例4之式〜11&-1之粗二級(:15醇(86.2%純 度=0.108莫耳)溶解在500毫升四氫呋喃中。加入2.63克 (12.5宅莫耳)彳+橡酸單水合物並將混合物加熱回流7小時。 V j 然後將其冷卻至室溫、用5 0 0毫升正己烧稀釋且每次用15 0 毫升飽和碳酸氫鈉溶液洗滌兩次,且亦用1 5〇毫升半濃縮 , 之氯化鈉溶液洗滌一次。將該合併之洗滌相用150毫升正 己烷萃取一次。合併有機相、用硫酸鈉乾燥並在旋轉蒸發 器上於+5 0°C下濃縮濾液至1〇毫巴。此產生39.5克88.3%純 度(根據HPLC)之黃色油狀式vmad之粗c15苯酚(定量產 率)。 實例6-式IX’iCn鱗鹽之合成 121373.doc -34- 20081109549.1 g of the crude secondary (~15 alcohol (86.2% purity = 0.108 mol) from the formula 11 to 11 & -1 was dissolved in 500 ml of tetrahydrofuran. 2.63 g (12.5 house mole) 彳 + rubber acid was added. The monohydrate was heated and refluxed for 7 hours. Vj was then cooled to room temperature, diluted with 500 mL of hexane and washed twice with 150 mL of saturated sodium bicarbonate solution, and 1 5 The solution was washed once with a half-concentrated solution of sodium chloride. The combined washed phases were extracted once with 150 ml of n-hexane. The organic phases were combined, dried over sodium sulfate and concentrated on a rotary evaporator at +50 ° C. To 1 mbar. This yielded 39.5 g of 88.3% purity (according to HPLC) of crude crude C15 phenol (quantitative yield) of the crude oil of formula vmad. Example 6 - Synthesis of the formula IX'iCn scale salt 121373.doc -34 - 200811095

a)自式VIIIa-1之C15苯酸 將1.51克來自實例5之式VIIIa_l之C15苯酚(88_3%純度 =4·42毫莫耳)溶解在10毫升二氯甲烷中。在〇它下,逐滴加 入1·56克(4·5毫莫耳)三苯基膦氫溴酸鹽存於18毫升二氯甲 烷中之溶液並將混合物在〇°C下再攪拌1小時且在室溫下再 1小時。然後在旋轉蒸發器上於+5(TC下濃縮混合物至5毫 巴。此產生2·65克作為殘留物之式IX,之粗鱗鹽。為了結 晶,將殘留物溶解在20毫升乙腈中。將此回流加熱15分 鐘、冷卻並在0°C下再攪拌1小時。過濾出晶體、用少量冷 乙腈洗務並在+ 50 °C/20毫巴下乾燥。 重量:1.21克式1乂’之(:15鱗鹽(理論值之49.3%) 熔點:222.5-223〇C 藉助HPLC之純度:98.8% 在旋轉蒸發器上於+5(TC下濃縮濾液至20毫巴。此產生 1.24克淺褐色黏性油狀殘留物,其中式以,之鎸鹽之含量為 39.9°/。(藉助 HPLC)。 b)自式VIIa-Ι之二級c15醇 將39·2克來自實例4之式vila-l之二級cls醇(純度 86.2% ; =86.6毫莫耳)溶解在2〇〇毫升二氣甲烷中。經丄小 時,在〇°C下逐滴加入31.2克三苯基膦氫溴酸鹽存於18〇毫 升二氯曱烷中之溶液。將混合物在〇r下再攪拌丨小時及在 121373.doc -35- 200811095 室溫下再攪拌H、時。為使鱗鹽結晶,在大氣壓下蒸餾出 溶劑且同時加入500毫升乙腈直至達到轉變溫度+8〇它。 將所得懸浮液冷卻至〇t、在〇t下再攪拌丨小時並過濾 出產物。將濾液用少量冷乙腈洗滌並在+5(rc /2〇毫巴下乾 燥。 重里· 17.3克式IX之C15鱗鹽(理論值之36.0%) 藉助HPLC之純度:96.7%a) C15 benzoic acid from formula VIIIa-1 1.51 g of C15 phenol from formula VIIIa-1 (88-3% purity = 4.42 mmol) was dissolved in 10 ml of dichloromethane. Under the hydrazine, a solution of 1.56 g (4.55 mmol) of triphenylphosphine hydrobromide in 18 ml of dichloromethane was added dropwise and the mixture was stirred at 〇 ° C for an additional hour. And at room temperature for another hour. The mixture was then concentrated on a rotary evaporator to +5 (TC) to 5 mbar. This gave 2,65 g of crude salt of formula IX as a residue. To crystallize, the residue was dissolved in 20 ml of acetonitrile. This was heated under reflux for 15 minutes, cooled and stirred for an additional 1 hour at 0 ° C. The crystals were filtered, washed with cold cold acetonitrile and dried at + 50 ° C / 20 mbar. Weight: 1.21 g. (: 15 scale salt (49.3% of theory) Melting point: 222.5-223 〇C Purity by HPLC: 98.8% The filtrate was concentrated to 20 mbar at +5 (TC) on a rotary evaporator. This gave 1.24 g of light. a brown viscous oily residue, wherein the content of the sulfonium salt is 39.9 ° / (by HPLC) b) the secondary c15 alcohol from the formula VIIa-Ι will be 39. 2 g from the vila of the example 4 -l of the second-stage cls alcohol (purity 86.2%; = 86.6 millimoles) dissolved in 2 ml of di-methane. After a few hours, 31.2 g of triphenylphosphine hydrobromic acid was added dropwise at 〇 ° C. The salt was stored in 18 ml of dichloromethane. The mixture was stirred for another hour at 〇r and stirred at room temperature of 121373.doc -35-200811095. The salt crystallized, the solvent was distilled off under atmospheric pressure and 500 ml of acetonitrile was added at the same time until the transition temperature was reached + 8 Torr. The obtained suspension was cooled to 〇t, stirred for another hour under 〇t and the product was filtered off. Wash with cold acetonitrile and dry at +5 (rc /2 mbar). Refilled 17.3 g of C15 sulphate of formula IX (36.0% of theory) Purity by HPLC: 96.7%

熔點:218.5-219°C 在旋轉蒸發器上於+50°C下濃縮濾液至20毫巴。將殘留 物溶解在100毫升乙腈中。將混合物在+7〇°c下再攪拌丨5分 鐘、冷卻至0°C、並在0°C下攪拌1小時。過濾出第二結晶 物、用少量冷乙腈洗滌並在+5 0°C/20毫巴下乾燥。 重量:17.4克式IX’之C15鱗鹽(理論值之36.2%) 藉助HPLC之純度:99.4% 式IX’之C15鎮鹽的總產率:理論值之72.2%。 在旋轉蒸發器上於+50°C下濃縮第二結晶物之濾液至2〇 毫巴。此產生18.0克具有21.1%(藉助HPLC)式IX,之鳞鹽含 量之發泡體狀物質。 實例7-式VIIIa-OH之C15苯酚之合成Melting point: 218.5-219 ° C The filtrate was concentrated to 20 mbar at +50 ° C on a rotary evaporator. The residue was dissolved in 100 ml of acetonitrile. The mixture was stirred at +7 ° C for an additional 5 minutes, cooled to 0 ° C, and stirred at 0 ° C for 1 hour. The second crystals were filtered off, washed with a small amount of cold acetonitrile and dried at <RTIgt;</RTI> Weight: 17.4 g of C15 scale salt of formula IX' (36.2% of theory) Purity by means of HPLC: 99.4% Total yield of C15 sulphate of formula IX': 72.2% of theory. The filtrate of the second crystals was concentrated to 2 mbar at +50 ° C on a rotary evaporator. This gave 18.0 g of a foamy material having a scale salt content of 21.1% (by HPLC) of formula IX. Example 7 - Synthesis of C15 phenol of formula VIIIa-OH

將1.96克來自實例4之式VIIa-Ι之粗二級C15醇(86.2%純 度;=4.31毫莫耳)溶解在1〇毫升四氫呋喃中。加入0.9克 121373.doc -36- 200811095 (50¾莫耳)水及240毫克擰檬酸單水合物且然後將混合物回 流加熱5小時。將其冷卻至室溫、用25毫升甲基第三丁基 醚稀釋並用5毫升飽和碳酸氫鈉溶液洗滌一次且每次用5毫 升水洗滌兩次。有機相用硫酸鈉乾燥並在旋轉蒸發器上於 + 50°C下將其濃縮至1〇毫巴。 此產生0.87克在靜置時結晶之高度黏性黃色油。式 VIIIa-OH之C15苯酚的含量(藉助HPLC) : 65·4% ;此對應於 式VIIIa_OHi C"苯酚的產率為理論值之574%。為了定 性,將粗產物加熱溶解在4毫升甲苯中;將其冷卻至並 在〇°C下靜置1小時。過濾出晶體、用少量冷甲苯洗滌並在 50°C/20毫巴下乾燥。 重量·· 190毫克式VIIIa-OH之C15苯酚 熔點:132-134°C 藉助HPLC之純度:94.8% 實例8 -式IVa1-1之Cls結構單元之合成1.96 g of the crude secondary C15 alcohol of formula VIIa-oxime from Example 4 (86.2% purity; = 4.31 mmol) was dissolved in 1 mL of tetrahydrofuran. 0.9 g of 121373.doc -36-200811095 (503⁄4 mol) of water and 240 mg of citric acid monohydrate were added and the mixture was then heated back for 5 hours. It was cooled to room temperature, diluted with 25 ml of methyl t-butyl ether and washed once with 5 ml of saturated sodium hydrogen carbonate solution and twice with 5 ml of water each time. The organic phase was dried over sodium sulphate and concentrated on a rotary evaporator to <RTIgt;</RTI> This produced 0.87 grams of a highly viscous yellow oil that crystallized upon standing. The content of C15 phenol of the formula VIIIa-OH (by HPLC): 65.4%; this corresponds to the formula VIIIa_OHi C" The yield of phenol is 574% of theory. For the purpose of characterization, the crude product was dissolved in 4 ml of toluene by heating; it was cooled and allowed to stand at 〇 ° C for 1 hour. The crystals were filtered, washed with a small amount of cold toluene and dried at 50 ° C / 20 mbar. Weight·· 190 mg of C15 phenol of the formula VIIIa-OH Melting point: 132-134 ° C Purity by means of HPLC: 94.8% Example 8 - Synthesis of Cls structural unit of the formula IVa1-1

將36·3克來自實例1之式iva^ic”結構單元(97·7%純度) (藉助GC分析為97.7%純度;=〇·〇98莫耳)溶解在4〇〇毫升四 氫呋喃中。在0°C下,經1小時注入62 2克用4〇〇毫升甲苯 稀釋之雙(2-甲氧基乙氧基)二氫化鈉鋁之65%濃度的甲苯 溶液。將混合物在0°C下再攪拌2小時。為了實施處理,在 (TC下首先逐滴加入33毫升乙醇與33毫升正己烷之混合 121373.doc -37- 200811095 物,繼而滴加33毫升15。/。濃度的氫氧化鈉溶液。然後加入 65毫升水。將混合物加熱至室溫’加入14〇毫升正己烷並 ^離出水性底相。將有機相每次請毫升半濃縮之氯化納 溶液洗滌三次。將合併之有機相用4〇毫升甲苯萃取一次。 將合併之有機相經硫酸鈉乾燥並在旋轉蒸發器上K+6(rc 下濃縮至5毫巴。此產生36·5克黃色黏性油狀殘留物,其 中式IVa'-liCb結構單元之含量為88 6%(藉助gc分析)。 此對應於理論值之90.7%的產率。 實例9-式Va,-a之Cls結構單元之合成36. 3 g of the iva^ic" structural unit from Example 1 (97.7% purity) (97.7% purity by GC analysis; = 〇·〇 98 mol) was dissolved in 4 mL of tetrahydrofuran. At 2 ° C, 62 2 g of a 65% strength toluene solution of aluminum bis(2-methoxyethoxy)dihydride diluted with 4 ml of toluene was injected over 1 hour. The mixture was at 0 ° C. Stirring was continued for 2 hours. To carry out the treatment, a mixture of 33 ml of ethanol and 33 ml of n-hexane was first added dropwise (TC373.doc-37-200811095), followed by dropwise addition of 33 ml of 15% sodium hydroxide. Solution. Then add 65 ml of water. Heat the mixture to room temperature. Add 14 ml of n-hexane and remove the aqueous bottom phase. Wash the organic phase three times with half of the concentrated sodium chloride solution. The phases were extracted once with 4 mL of toluene. The combined organic phases were dried over sodium sulfate and concentrated to 5 mbar. Wherein the content of the formula IVa'-liCb structural unit is 88 6% (by gc analysis). This corresponds to the theoretical value of 9 0.7% yield. Example 9 - Synthesis of Cls structural unit of formula Va, -a

將36.3克來自實例8之式IVa,_i之粗Ci5結構單元(88.6%純 度=88.4毫莫耳)溶解在100毫升四氫呋喃中。加入18克水及 2.1 5克40%濃度的對-甲苯續酸單水合物之水溶液(=5 〇毫莫 耳對-f苯磺酸)並將混合物在室溫下再攪拌丨小時。為了實 施處理,將批料用500毫升甲基第三丁基醚稀釋。將其用 100毫升飽和碳酸氫鈉溶液洗滌一次且每次用丨〇〇毫升水洗 滌兩次、用硫酸鈉乾燥且在旋轉蒸發器上於+6〇〇c下濃縮 至20宅巴。此產生24.8克灰棕色固體狀式〜、之粗^"結 構單元之殘留物,其具有90·6%純度(藉助GC分析)。此對 應於定量產率。 為了疋性,將式Va’-a之粗產物加熱溶解在150毫升甲苯 121373.doc -38- 200811095 中。過濾白色溶液直至透過濾色器表明其達到透明為止並 冷卻至o°c。所得懸浮物在0°c下攪拌i小時並過濾。用少 量冷甲苯洗滌遽餅並在5 0 °C /2 0毫巴下乾燥。 重量:15.7克(藉助GC分析99.1%純度)36.3 g of the crude Ci5 structural unit of formula IVa, _i from Example 8 (88.6% purity = 88.4 mmol) was dissolved in 100 mL of tetrahydrofuran. 18 g of water and 2.1 g of a 40% strength aqueous solution of p-toluene acid monohydrate (= 5 〇 mmol to -f benzenesulfonic acid) were added and the mixture was stirred at room temperature for an additional hour. For the treatment, the batch was diluted with 500 ml of methyl tert-butyl ether. It was washed once with 100 ml of saturated sodium bicarbonate solution and twice with liters of water each time, dried over sodium sulfate and concentrated on a rotary evaporator to <RTIgt; This resulted in a residue of 24.8 g of a pale brown solid of the form <"""" This corresponds to a quantitative yield. For the sake of inertness, the crude product of the formula Va'-a was dissolved in 150 ml of toluene 121373.doc -38 - 200811095. The white solution was filtered until it passed through a color filter to indicate that it was transparent and cooled to o. The resulting suspension was stirred at 0 ° C for 1 hour and filtered. The cake was washed with a small amount of cold toluene and dried at 50 °C / 2 0 mbar. Weight: 15.7 g (99.1% purity by GC analysis)

熔點:139-140°C 實例10-式Via’-1之C15酮之合成Melting point: 139-140 ° C Example 10 - Synthesis of C15 ketone of Via'-1

將14.9克(60.1毫莫耳)來自實例9之式Va,_a之結晶產物懸 浮在110毫升曱苯中。在室溫下加入ι73毫克(〇·9毫莫耳) 對-甲苯績酸單水合物。隨後注入21·7克(3〇〇毫莫耳)乙稀 基乙醚,將混合物的溫度升高至+5(rc並將其在+5〇r下再 攪拌2小時。將混合物冷卻至室溫,加入15毫升飽和碳酸 氫鈉/谷液並將其再劇烈攪拌5分鐘。分離出水性底相並將 有機頂相用1 5毫升飽和碳酸氫鈉溶液洗滌一次且亦每次用 6毫升水洗滌兩次、用硫酸鈉乾燥並在旋轉蒸發器上於+6〇 C下濃縮至1耄巴。此產生22·5克黃色油狀式vw—丨之 酮(粗產率94.1%)。 實例11-式VIIa,-l之二級Cl5醇之合成 121373.doc -39· 20081109514.9 g (60.1 mmol) of the crystalline product of formula Va,_a from Example 9 was suspended in 110 ml of toluene. Iota 73 mg (〇·9 mmol) of p-toluene acid monohydrate was added at room temperature. Subsequently, 21.7 g (3 Torr) of ethyl ether was poured, the temperature of the mixture was raised to +5 (rc and stirred for another 2 hours at +5 Torr). The mixture was cooled to room temperature. Add 15 ml of saturated sodium bicarbonate/cold solution and stir vigorously for another 5 minutes. The aqueous bottom phase is separated and the organic top phase is washed once with 15 ml of saturated sodium bicarbonate solution and also with 6 ml of water each time. It was dried twice with sodium sulfate and concentrated to 1 Torr on a rotary evaporator at <RTI ID=0.0>> - Synthesis of secondary Cl5 alcohols of formula VIIa, -l 121373.doc -39· 200811095

將22.3克來自實例10之式via,-l之粗C15酮(56.9毫莫耳, 原樣使用)溶解在230毫升四氫呋喃中。在下,經i小時 注入17.7克用230毫升曱苯稀釋之雙(2_甲氧基乙氧基)二氫 化納銘之6 5 % >辰度的甲苯溶液。將混合物在〇它下再擾拌工 小時且然後首先注入11毫升乙醇與U毫升己烷之混合物且 Ik後注入11宅升15 %濃度的氫氧化鈉溶液。將混合物在〇 下再攪拌15分鐘,加入22毫升水及40毫升己烷且將其加熱 至室溫。分離出水性底相並將有機相每次用丨丨毫升半濃縮 之氯化鈉溶液洗滌三次。將水相合並且用丨丨毫升甲苯再萃 取一次。將合併之有機相用硫酸鈉乾燥並在旋轉蒸發器上 於+60°C下濃縮至1毫巴。此產生23.8克淺褐色黏性油狀之 式VIIaf-l之粗二級C15醇。 實例12-式IX之Ci5鱗鹽之合成22.3 g of crude C15 ketone (56.9 mmol, used as received) from the form of Example 10, vial, was dissolved in 230 mL of tetrahydrofuran. Next, 17.7 g of a toluene solution of bis(2-methoxyethoxy)dihydrogenated Na 6 6 % > Chen was diluted over 1 hour. The mixture was again scrambled for a few hours and then a mixture of 11 ml of ethanol and U ml of hexane was first injected and 11 k of a 15% strength sodium hydroxide solution was injected after Ik. The mixture was stirred for a further 15 minutes under hydrazine, 22 ml of water and 40 ml of hexane were added and then allowed to warm to room temperature. The aqueous bottom phase was separated and the organic phase was washed three times each time with a half-concentrated sodium chloride solution. The water was combined and extracted once more with mM ml of toluene. The combined organic phases were dried over sodium sulfate and concentrated to 1 mbar at EtOAc. This gave 23.8 g of a crude secondary C15 alcohol of the formula VIIaf-1 as a light brown viscous oil. Example 12 - Synthesis of Ci5 scale salt of formula IX

將20.5克來自實例11之式vila’-l之粗二級c15醇(52.0毫 莫耳,原樣使用)溶解在1〇5毫升二氣甲烷中。經i小時, 在0°C下逐滴加入1 6.25克(46.9毫莫耳)三苯基膦氫溴酸鹽 存於9 5宅升一氯曱燒中之溶液。將混合物加熱至室溫且然 後回流加熱2小時。然後在旋轉蒸發器上於+5(rc下移除溶 121373.doc -40- 200811095 劑至5宅巴。此產生28·5克根據HPLC分析含有68.9%式IX 之鎸鹽之赭色固體。此對應於式Va,-a之Cl5結構單元之約 66%理論值的產率。將粗產物溶解在1〇〇毫升丙酮中。藉 由添加200毫升乙酸乙酯沈澱出式〗又之鱗鹽。分離出固體 並在+50°C/20毫巴下乾燥。20.5 g of the crude secondary c15 alcohol (52.0 mmol, used as received) from the vila'-l of Example 11 was dissolved in 1 mL of 2 mL of methane. After i hours, a solution of 1. 6.25 g (46.9 mmol) of triphenylphosphine hydrobromide in 9 liters of monochloropyrene was added dropwise at 0 °C. The mixture was heated to room temperature and then heated under reflux for 2 hours. The solution 121373.doc -40 - 200811095 was then removed on a rotary evaporator to +5 (rc) to 5 mbar. This yielded 28.5 g of a dark solid containing 68.9% of the hydrazine salt of formula IX according to HPLC. This corresponds to a yield of about 66% of the theoretical value of the Cl5 structural unit of the formula Va, -a. The crude product is dissolved in 1 ml of acetone. The precipitate is precipitated by adding 200 ml of ethyl acetate. The solid was separated and dried at +50 ° C / 20 mbar.

重量:15.4克 熔點:234-235°C 實例13-式I之3,3’-二羥基異二十二碳浠撐二偏三曱基苯之 合成,Weight: 15.4 g Melting point: 234-235 ° C Example 13 - Formula 3 of 3, 3'-dihydroxyisodocosacarbenium dimercaptobenzene,

將136.8克(0.248莫耳)根據實例12製備的式以之。5鱗鹽於 室溫下懸浮在560毫升乙醇中。隨後加入185克(〇丨^莫 耳)式X之2,7_二甲基辛_2,4,6_三浠二駿 及170毫升U2_環氧丁烷。將混合物回流加熱2〇小時。將所 得懸浮物冷卻至(TC且在代下授拌i小時。過爐出沈搬並 將濾餅每次用100毫升的乙醇洗滌兩次。 為更好純化,將濕濾餅溶解在600毫升四氫呋喃中。將 懸:物回流加熱且保持回流3〇分鐘。將混合物熱過濾,·隨 後蒸餾出350毫升溶劑且同時逐滴加入75〇毫升乙腈。將晶 體懸浮液喊20小時。然後將料液冷卻至室溫、授掉1 121373.doc -41 - 200811095 小時並過濾。將濾餅每次用50毫升乙腈洗滌兩次並在50°C/20 毫巴下乾燥。 重量:38·9克(理論值之61.5%)136.8 g (0.248 mol) of the formula prepared according to Example 12 was used. 5 scale salts were suspended in 560 ml of ethanol at room temperature. Subsequently, 185 g of 2,7-dimethyloctyl-2,4,6-triazine and 170 ml of U2_butylene oxide were added. The mixture was heated under reflux for 2 hrs. The resulting suspension was cooled to (TC and mixed for 1 hour under the mixture. The furnace was taken up and the filter cake was washed twice with 100 ml of ethanol each time. For better purification, the wet cake was dissolved in 600 ml. In tetrahydrofuran, the suspension was heated under reflux and kept at reflux for 3 minutes. The mixture was filtered hot. Then, 350 ml of solvent was distilled off while 75 ml of acetonitrile was added dropwise. The crystal suspension was shouted for 20 hours. Cool to room temperature, transfer 1 121373.doc -41 - 200811095 hours and filter. Wash the filter cake twice with 50 ml acetonitrile and dry at 50 ° C / 20 mbar. Weight: 38 · 9 g ( 61.5% of the theoretical value)

熔點:228-230°C HPLC : 98.9%純度 EM (CHCI3) : 2176,在 465奈米處 121373.doc -42-Melting point: 228-230 ° C HPLC : 98.9% purity EM (CHCI3): 2176 at 465 nm 121373.doc -42-

Claims (1)

200811095 十、申請專利範圍: 1· 一種製備式I之3,3,-二羥基異二十二碳烯撐二偏三甲基苯 (3,3’-dihydroxyisoreI1ieratene)之方法,200811095 X. Patent application scope: 1. A method for preparing 3,3,-dihydroxyisodocosatrimethylenetriene (3,3'-dihydroxyisoreI1ieratene) of formula I, 其包括至少下列步驟之一: a)使式II之單縮酮:It comprises at least one of the following steps: a) making a monoketal of formula II: 其中’该等基團R1係相同或不同且係-烧基基 團’或該等兩個基團R1共同係雙鍵結之C2_c12-伸烧 基基團’亦即共同與其連接之原子形成環狀縮酮; 與式Ilia或Illb之金屬化快烴反應:Wherein the groups R1 are the same or different and the t-alkyl group or the two groups R1 are commonly double-bonded C2_c12-alkylene groups, that is, the atoms connected thereto form a ring a ketal; a metallized fast hydrocarbon reaction with the formula Ilia or Illb: 其中’ R2係可藉由水解轉化為羥基基團之醚、甲矽 烧基醚或縮醛保護基團且Μι係Li、Na、K、MgCl、 MgBr、Mgl或Mg1/2,該式nib之化合物可為E同分異 構體、Z同分異構體或E/z同分異構體之混合物; 以形成式IVa或IVb之C15結構單元, 121373.doc 200811095Wherein 'R2 is an ether, formazanyl ether or acetal protecting group which can be converted into a hydroxyl group by hydrolysis and the oxime is Li, Na, K, MgCl, MgBr, Mgl or Mg1/2, the formula nib The compound may be a mixture of E isomers, Z isomers or E/z isomers; to form a C15 building block of formula IVa or IVb, 121373.doc 200811095 若適宜,繼而藉由使式IVa或IVb之C15結構單元與還 原劑反應以將三鍵轉化為雙鍵得到式IVa’或IVb’之C15 結構單元,If appropriate, the C15 building block of formula IVa' or IVb' is then obtained by reacting a C15 building block of formula IVa or IVb with a reducing agent to convert the triple bond to a double bond, IVa,IVa, IVb, b)藉由水解消去式IVa、IVb、IVa1或IVb’之C15結構單元 的保護基團,得到式Va或Vb之去保護C15結構單元,IVb, b) deprotecting the C15 structural unit of formula Va or Vb by hydrolysis to eliminate the protecting group of the C15 structural unit of formula IVa, IVb, IVa1 or IVb', 繼而引入可藉由水解消去之OH保護基團得到式Via 或VIb之C15酮,Substituting an OH protecting group which can be eliminated by hydrolysis to obtain a C15 ketone of the formula Via or VIb, Via 其中 γ 係 CH =CH —或一C=C一, 且 R2係可藉由水解轉化為羥基基團之醚、曱矽烷基醚 或縮醛保護基團, 121373.doc 200811095 C)藉由還原幾基基團使式VIa或vIb之ci5酮反應為式 Vila 或 Vllb 之二級 c15 醇,Via wherein γ is CH=CH—or C=C—, and R2 is an ether, decyl ether or acetal protecting group which can be converted to a hydroxyl group by hydrolysis, 121373.doc 200811095 C) by reduction a benzyl group reacts a ci5 ketone of formula VIa or vIb to a secondary c15 alcohol of the formula Vila or Vllb, 其中Y及R2係如步驟b)中之式VIa中所定義, d)使式Vila或VIIb之二級Ci5醇與強有機或無機酸Ηχ& 與三芳基膦Ρ(芳基h反應,χ係該酸Ηχ之陰離子且芳Wherein Y and R2 are as defined in formula VIa in step b), d) reacting a secondary Ci5 alcohol of the formula Vila or VIIb with a strong organic or inorganic acid cerium & with a triarylphosphonium (aryl h, lanthanide) The acid anion and aromatic 基係經取代或未經取代之匕/以芳基基團,經過式 Villa或Vlllb之可分離中間體Ci5苯酚,a substituted or unsubstituted oxime/aryl group through a separable intermediate of formula Villa or Vlllb, Ci5 phenol, viiib R3係OH或R2,且R2及γ将如牛_ 夂Y係如步驟b)中之式Via中所定 義, 得到式IX或IX’之c15鱗鹽,Viiib R3 is OH or R2, and R2 and γ are as defined in the formula Via in the step b) to obtain the c15 scale salt of the formula IX or IX'. 該式IX*之Ci5鱗鹽同樣可藉由 式IX之c15鎮鹽, 二鍵之部分氫化轉化為 e)使該式IXiC"鱗鹽與式又 叭(2,7_一甲基辛-2,4,6-三烯 二醛: 121373.doc 200811095The Ci5 scale salt of the formula IX* can also be converted to e by partial hydrogenation of the c15 of the formula IX, and the IXiC"scale salt and the formula (2,7-monomethyl osin-2) ,4,6-trienedialdehyde: 121373.doc 200811095 以雙重魏悌希(Wittig)反應方式反應得到式I之化合 物, 該等式 iVb、IVb,、Vb、VIb、Vllb、Vlllb、XI 及 IX, 之化合物可為E同分異構體、Z同分異構體或E/Z同分異 構體混合物。 2· 3. 4. 如請求項1之方法,其中至少實施步驟d)及e)。 如請求項1或2之方法,其中在方法步驟c)中使用方法步 驟b)中製備的、未經分離及未經進一步處理之式Via及 VIb之C15酮來製備式VIIa4VIIb之二級Cl5醇。 如請求項1至3中任一項之方法,其中,在方法步驟d) 中’為使該式Vila或Vllb之二級C15醇反應以得到式IX或 ΙΧ’之C15鱗鹽,強酸HX使用氫溴酸或氫氣酸,且三芳基 膦P(芳基)3使用三苯基膦。 如請求項1至4中任一項之方法,其中,在方法步驟d) 中,式Villa或Vlllb之中間體未經分離,而是使式Vila或 Vllb之二級C15醇直接反應以得到該式IX或IX’之C15鱗 轉 Ο 一種式IVa或IVb之C15結構單元,The compound of formula I is obtained by a double Wittig reaction. The compounds of the formulas iVb, IVb, Vb, VIb, Vllb, Vlllb, XI and IX can be E isomers and Z is different. A mixture of bodies or E/Z isomers. 2. The method of claim 1, wherein at least steps d) and e) are implemented. The method of claim 1 or 2, wherein in the method step c), the C15 ketone of the formula Via ia and VIb prepared in the method step b) without isolation and without further treatment is used to prepare the secondary Cl5 alcohol of the formula VIIa4VIIb. . The method of any one of claims 1 to 3, wherein in the method step d) 'to react a secondary C15 alcohol of the formula Vila or Vllb to obtain a C15 scale salt of the formula IX or ΙΧ', a strong acid HX is used Hydrobromic acid or hydrogen acid, and triarylphosphine P (aryl) 3 uses triphenylphosphine. The method of any one of claims 1 to 4, wherein in the method step d), the intermediate of the formula Villa or V11lb is not separated, but the secondary C15 alcohol of the formula Vila or Vllb is directly reacted to obtain the C15 scale of formula IX or IX', a C15 building block of formula IVa or IVb, 121373.doc 200811095 其中 R 係相同或不同且係Ci-Cs -烧基基團或該等兩個基團y 共同係雙鍵結之伸烷基基團,亦即共同與其 連接之原子形成環狀縮酮,且 R2係可藉由水解轉化為羥基基團之醚、甲石夕烧基峻或 縮醛保護基團,且 該式IVbiC!5結構單元可為E同分異構體、z同分異構體 或E/Z同分異構體之混合物。 如請求項6之〇!5結構單元,其中式IVa係與下式相同:121373.doc 200811095 wherein R is the same or different and is a Ci-Cs-alkyl group or a two-bonded alkyl group of the two groups y, which is a ring-bonded atom a ketal, and R2 is an ether, a methacrylate or an acetal protecting group which can be converted into a hydroxyl group by hydrolysis, and the structural unit of the formula IVbiC!5 can be an E isomer, z is the same A mixture of isomers or E/Z isomers. As for the item 6 of the request! 5 structural unit, wherein the formula IVa is the same as the following formula: 一種式IVa,或IVb,之C15結構單元,a formula IVa, or IVb, a C15 structural unit, R1係相同或不同且係Ci-C8_烷基基團或該等兩個基團Rl 共同係雙鍵結之C2-Cl 2-伸烧基基團,亦即共同與其 連接之原子形成環狀縮酮,且 R2係可藉由水解轉化為羥基基團之醚、甲矽烷基醚或 縮酸保護基團,且 該式1Vb’之結構單元可為E同分異構體、z同分異構體 或E/Z同分異構體之混合物。 121373.doc 200811095 9·如請求項8之〇1$結構單元,其中式IVa,係與下式相同R1 is the same or different and is a Ci-C8_alkyl group or the two groups R1 are commonly a double-bonded C2-Cl2-extension group, that is, a ring formed by a common atom a ketal, and R2 is an ether, a methyl ketone ether or a carboxylic acid protecting group which can be converted into a hydroxyl group by hydrolysis, and the structural unit of the formula 1Vb' can be an E isomer, z is the same A mixture of constructs or E/Z isomers. 121373.doc 200811095 9. The structural unit of claim 1 of claim 8 wherein the formula IVa is the same as 10· —種式Va,-a之c15結構單元,10·—the c15 structural unit of the formula Va,-a, 11· 一種式Via或VIb之C15酮,11· A C15 ketone of the formula Via or VIb, 其中 Y係 一CH—CH —或一CSC —, 且 R係可精由水解轉化為控基基團之謎、甲秒烧基謎或縮 醛保護基團,且 該式VIb之C15酮可為E同分異構體、Z同分異構體或E/Z 同分異構體之混合物。 12.如請求項11之式Via之C15酮, 其中 γ 係 ~CH —CH ——或一CEC —, 且 R2係-0-CH(Me)-0-CH2CH3。 121373.doc -6 - 200811095 13· —種式Vila或Vllb之二級c15醇,Wherein Y is a CH-CH- or a CSC-, and the R-series can be converted from a hydrolysis to a mystery group, a methalone or an acetal protecting group, and the C15 ketone of the formula VIb can be A mixture of E isomers, Z isomers or E/Z isomers. 12. The C15 ketone of Via of the formula 11 wherein gamma is -CH-CH- or -CEC-, and R2 is -0-CH(Me)-0-CH2CH3. 121373.doc -6 - 200811095 13· - a secondary c15 alcohol of the formula Vila or Vllb, 其中 γ 係 CH == CH""—或 ~C=C—, 且 R係可藉由水解轉化為經基基團之鱗、甲石夕炫基醚或縮 醛保護基團,且 該式Vllb之二級C"醇可為E同分異構體、z同分異構體 或E/Z同分異構體之混合物。 14·如請求項12之式Vila之二級Ci5醇,其中R2係_〇_CH(Me)_ 〇-CH2CH3。 15· —種式Villa或Vlllb之C15苯酚,Wherein the γ system CH == CH""- or ~C=C-, and the R system can be converted into a group-based scale, a mazyl ether or an acetal protecting group by hydrolysis, and the formula The secondary C" alcohol of Vllb can be a mixture of E isomers, z isomers or E/Z isomers. 14. A secondary Ci5 alcohol of the formula Vila according to claim 12, wherein R2 is _〇_CH(Me)_〇-CH2CH3. 15·—C15 phenol of the type Villa or Vlllb, R係與OH或R2相同’且R2及Y係如請求項13之式VIIa中 所定義,且 該式VIlIbi Cb苯酚可為E同分異構體、z同分異構體或 E/Z同分異構體之混合物。 16·如請求項1 5之式Villa之C15苯紛,其中R3係與〇H或-〇-CH(Me)-〇-CH2CH3相同。 17· —種式IX或IX’之C15鱗鹽, 121373.doc 200811095R is the same as OH or R2' and R2 and Y are as defined in formula VIIa of claim 13, and the formula VI1Ibi Cb phenol may be E isomer, z isomer or E/Z a mixture of isomers. 16. The C15 benzene of the Villa of the formula 1 5, wherein the R3 is the same as 〇H or -〇-CH(Me)-〇-CH2CH3. 17·—C15 scale salt of formula IX or IX’, 121373.doc 200811095 p<(芳基)3x, 其中 X係強有機或無機酸HX之陰離子且 芳基係經取代或未經取代之C6-C14_芳基基團,且 該式IX或IX’之C15鎸鹽可為E同分異構體、Z同分異構體 或E/Z同分異構體之混合物。 18. —種製備式IX之鱗鹽的方法,p<(aryl) 3x, wherein X is an anion of a strong organic or inorganic acid HX and the aryl is a substituted or unsubstituted C6-C14_aryl group, and the C15 onium salt of the formula IX or IX' It may be a mixture of E isomers, Z isomers or E/Z isomers. 18. A method of preparing a scale salt of formula IX, 其包括使式Vila或Vllb之二級C15醇:It comprises a secondary C15 alcohol of the formula Vila or Vllb: 其中 γ 係 CH =CH —或 ~C=C—, R2係可藉由水解轉化為羥基基團之醚、甲矽烷基醚或縮 醛保護基團, 且 該式Vllb之二級C15醇可為E同分異構體、Z同分異構體 或E/Z同分異構體之混合物; 與強有機或無機酸HX及與三芳基膦P(芳基)3反應,X係 121373.doc 200811095 該酸HX之陰離子且 芳=係經取代或未經取代之cvc14_芳基基團, 以得到C15鱗鹽,倘若以其中γ係三鍵之式術或·作 為起始產物,則該cls鱗鹽之三鍵可藉由部分氫化轉化為 雙鍵以到達式IX之C15鱗鹽,該式IX之C15鱗鹽可為E同分 異構體、Z同分異構體或E/Z同分異構體之混合物。 121373.doc 200811095 七、指定代表圖: (一) 本案指定代表圖為:(無) (二) 本代表圖之元件符號簡單說明: 八、本案若有化學式時,請揭示最能顯示發明特徵的化學式:Wherein γ is CH=CH—or ~C=C—, and R2 is an ether, a methyl hydroxyalkyl ether or an acetal protecting group which can be converted into a hydroxyl group by hydrolysis, and the secondary C15 alcohol of the formula V11b can be a mixture of E isomers, Z isomers or E/Z isomers; with strong organic or inorganic acids HX and with triarylphosphines P(aryl)3, X series 121373.doc 200811095 The anion of the acid HX and the aryl = substituted or unsubstituted cvc14_aryl group to give a C15 scale salt, provided that the gamma triple bond is used as a starting product, the cls The triple bond of the scale salt can be converted to a C15 scale salt of the formula IX by partial hydrogenation to a C15 scale salt of the formula IX. The C15 scale salt of the formula IX can be an E isomer, a Z isomer or an E/Z. a mixture of isomers. 121373.doc 200811095 VII. Designated representative map: (1) The representative representative of the case is: (none) (2) The symbol of the symbol of the representative figure is simple: 8. If there is a chemical formula in this case, please reveal the best indication of the characteristics of the invention. Chemical formula: 121373.doc121,373.doc
TW096124761A 2006-07-07 2007-07-06 Method for producing 3,3'-dihydroxyisorenieratine and also novel intermediates therefor TW200811095A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06116819 2006-07-07

Publications (1)

Publication Number Publication Date
TW200811095A true TW200811095A (en) 2008-03-01

Family

ID=38474037

Family Applications (1)

Application Number Title Priority Date Filing Date
TW096124761A TW200811095A (en) 2006-07-07 2007-07-06 Method for producing 3,3'-dihydroxyisorenieratine and also novel intermediates therefor

Country Status (2)

Country Link
TW (1) TW200811095A (en)
WO (1) WO2008003737A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL6613365A (en) * 1965-10-07 1967-04-10
DE2964401D1 (en) * 1978-06-02 1983-02-03 Hoffmann La Roche Process for the preparation of cyclohexenyl derivatives, and intermediates produced in the synthesis
DE3377127D1 (en) * 1982-08-20 1988-07-28 Hoffmann La Roche Process for the preparation of astaxanthine and intermediates in the astaxanthine synthesis
DK171297B1 (en) * 1987-03-27 1996-08-26 Hoffmann La Roche Process for the preparation of cyclohexene derivatives as intermediates for the preparation of zeaxanthin and cyclohexene derivatives
DE19723480A1 (en) * 1997-06-04 1998-12-10 Basf Ag Process for the preparation of zeaxanthin, intermediates for this process and process for its preparation
WO2007090095A2 (en) * 2006-01-27 2007-08-09 Cardax Pharmaceuticals, Inc. Synthesis of carotenoid analogs or derivatives with improved antioxidant characteristics

Also Published As

Publication number Publication date
WO2008003737A1 (en) 2008-01-10

Similar Documents

Publication Publication Date Title
EP0667330B1 (en) Cyclohexanol derivative, agent and composition containing the same for imparting pleasantly cool feeling, process for producing the derivative, and intermediate therefor
DK171297B1 (en) Process for the preparation of cyclohexene derivatives as intermediates for the preparation of zeaxanthin and cyclohexene derivatives
EP3221334B1 (en) 6.alpha.-alkyl-6,7-dione steroids as intermediates for the production of steroidal fxr modulators
EP3221333B1 (en) 6.alpha.-alkyl-3,7-dione steroids as intermediates for the production of steroidal fxr modulators
EP3221332B1 (en) 5.beta.-6-alkyl-7-hydroxy-3-one steroids as intermediates for the production of steroidal fxr modulators
UA85862C2 (en) Selective estrogen receptor modulators for the treatment of vasomotor symptoms
IL192213A (en) Methods of making a ketal functionalized ester of a cyclic unsaturated acid or a salt thereof
Julian et al. Studies in the indole series. III. On the synthesis of physostigmine
JP4382910B2 (en) Method for producing 4,4'-diketo-carotenoid
TW200811095A (en) Method for producing 3,3'-dihydroxyisorenieratine and also novel intermediates therefor
US9079848B2 (en) 5-acetoxy-(E3)-3-pentenyl methoxymethyl ether and method for preparing (E3)-3-alkenyl acetate using the same
CN104592017B (en) The method for preparing 2- isopropylidene -5- methyl -4- hexenyl butyrate
ES2866148T3 (en) Method for producing 3,7-dimethyl-7-octenol and method for producing 3,7-dimethyl-7-octenyl carboxylate compound
Zweifel et al. The Synthesis of cis-and trans-δ-Pinenes via Hydroboration of Verbenene
CN101089008B (en) Dicyclic analog without ring A and ring B of omithogalum caudatum OSW-1 saponin and its synthesis process and use
TW203050B (en)
CN112010881A (en) Alkenyl boron compound and preparation method and application thereof
JPH0130817B2 (en)
Carpita et al. Synthesis of the racemic forms of carbon–carbon double bond locked analogues of strobilurins which are characterized by a 2-arylcyclopropane ring cis-substituted at C-1 by the methyl (E)-3-methoxypropenoate unit
Nozawa et al. Triterpenoid total synthesis. Part 5. 1 Synthetic disproof of the triterpene structure proposed for naurol A, a cytotoxic metabolite of a Pacific sponge
US3002008A (en) 16-alkenyl and 16-alkynylestratriene-3,16,17-triols and ethers thereof
JP3310399B2 (en) Method for producing cyclic acetal of 3-formyl-2-butenyl-triphenylphosphonium chloride
TW200811094A (en) Process and novel intermediates for the preparation of 3,3'-dihydroxyisorenieratine
US2849495A (en) Preparation of 3, 4-dehydro-beta-carotene
Mori New synthesis of (11 Z, 13 Z)-11, 13-hexadecadienal, the female sex pheromone of the navel orangeworm